Solorank
Login

Cached score snapshot

US.MCK · McKesson Corporation

110分制 59.4/110；5D動能v2 18/50；排序分 77.4/160

Back to ranking Open volume snapshot
Ranking score 77.4/160
Main score 59.4/110
5D momentum v2 18/50
Rank #64
Setup grade B 68.9

Score breakdown

觀望

Medium twelvedata

Score and price trend

B 68.9 lift 1.26x

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 07-21 09-11 10-21 11-06 11-24 $789.42$928.21$1067.01 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling calibration best · score 2.463 · anchors 120 +0.71% -1.39% / +3.43% 57.5% 2.5% Actual +4.47% · vs median +3.76% · inside 25-75 band
30D observation -2.08% -7.74% / +2.49% 40% 40% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 +0.39% -1.35% / +2.71% 55.6% 4.4% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-07-21 → 2026-11-24 · 148 archived points · 1 Improving turn signal · 4 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 77.4
Display grade 觀望
Model version cursor_18_27_news_v2_160
Main score 59.4/110 (觀望)
5D momentum v2 18/50 (弱)
Score with momentum v2 77.4/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 897.2955
ma50 888.4096
close 961.88
prevClose 955.76
avgVolume20 812350
volumeRatio 0.92
changePercent 0.64

Metrics snapshot

close 961.88
volume 743592
changePercent 0.64

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 59.4/110
Main rating 觀望
5D momentum v2 18/50
Score with momentum v2 77.4/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.4/5 · 一般
Dimension score 3.4/5
Dimension grade 一般

Sub-items

pbPoints 0
pePoints 0.2
epsPoints 0.75
roePoints 0
debtPoints 0.5
marginPoints 0
turnoverUsdM 715.2463
volumePoints 0.5
revenuePoints 0.6
dividendPoints 0.3
marketCapPoints 0.5

資金流 — 13.2/20 · 一般
Dimension score 13.2/20
Dimension grade 一般

Sub-items

cmfPoints 0.8
mfiPoints 2.4
obvPoints 4
vwapPoints 4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.MCK
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 10.2/15 · 一般
Dimension score 10.2/15
Dimension grade 一般

Sub-items

vix

score 2.4

details

source twelvedata+fred
vixClose 15.21

trend

score 4

details

qqq

ma20 741.336
ma50 726.5544
name QQQ
close 743.57
points 2

spy

ma20 769.869
ma50 768.6026
name SPY
close 778.01
points 2
source twelvedata+fred
atrPct 2.506
atrPoints 3
cciPoints 0.8
vixPoints 2.4
marketTrendPoints 4

催化劑 — 2/20 · 較差
Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 8
catalystCount 0
catalystPoints 2

風險管理 — 6.8/10 · 一般
Dimension score 6.8/10
Dimension grade 一般

Sub-items

position

score 1.6

details

atrPct 2.506
turnoverUsdM 715.2463
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.MCK
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 913.6704

strength_details

ma_score 2
atr_score 2
rsi_score 0.5
macd_score 3
volume_score 1
market_adjustment 1
risk_reward_ratio 1.1
stop_loss_percent 5
take_profit_price 1015.3123
target_multiplier 1.9
technical_strength 1.75
take_profit_percent 5.6
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.012
diversificationPoints 2

技術信號 — 20.8/30 · 一般
Dimension score 20.8/30
Dimension grade 一般

Sub-items

bbPoints 3
adxPoints 3
sarPoints 2.4
vcpPoints 0.9
macdPoints 4

vcpPayload

vcp_pass false
vcp_score 0.9
vcp_reason 站上MA50；收盤突破20日高位；Ready=N；Confirm=Y

vcp_metrics

up_days 7
vol_ref 848630
down_days 2
vcp_ready false
above_ma50 true
avg_vol_10 717310
avg_vol_20 832720
avg_vol_30 848630
range_pct_10 0.1133
range_pct_20 0.1133
range_pct_30 0.1133
up_expand_ok false
lookback_used 59
near_20d_high true
contraction_ok false
down_shrink_ok false
up_expand_days 1
breakout_20d_ok true
vol_ratio_10_30 0.8453
dist_to_20d_high -0.0059
down_shrink_days 2
breakout_level_20d 956.24
vcp_breakout_confirm true
contraction_ratio_10_30 1
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction false
kdjAdxPoints 0.7
rsiKdjPoints 2.4
volumeWeight 2
maCrossPoints 2.4
shortRsiPoints 0.8
shortMacdPoints 0.4
volConfirmPoints 0
volumePointsTechnical 0.8

情緒分析 — 3/10 · 較差
Dimension score 3/10
Dimension grade 較差

Sub-items

sentiment

score 3

details

source finnhub_news_keyword_model
articleCount 8
negativeHits 0
positiveHits 1
sentimentScoreRaw 0.3

sentimentData

raw {"id":142821758,"url":"https://finnhub.io/api/news?id=281a1eb6ee8f02bdc10783752dc8224a241eda5565d2625fab63ff404e67c0f6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson has been a powerful long term winner. With the share price now at US$938.84, the real question is whether the business can keep generating cash flows that line up with that kind of run. With a Discounted Cash Flow (DCF) view available, the focus turns squarely to what the current price implies about the money the company can return to shareholders over time. Over the past 5 years the stock has delivered a very large 379.8% return, which puts a lot of past optimism about McKesson's...","category":"company","datetime":1791818058,"headline":"McKesson (MCK) Stock Could Be 43% Undervalued Despite Its $1.4B Infusion Deal"}, {"id":142821757,"url":"https://finnhub.io/api/news?id=fbb0d7b782fa3b4aba78feb7fb325d6b48482c6a3eb9c1d87eb5906b0a671cef","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson (MCK) shares are in focus after the distributor reached an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032, reinforcing a long-running customer relationship. McKesson’s share price has been trending higher, with a 30-day share price return of 6.5% and a 90-day move of 16.9%. The 1-year total shareholder return of 22.5% and 5-year total shareholder return of about 3.8x suggest that recent contract wins and distribution...","category":"company","datetime":1791814584,"headline":"McKesson (MCK) Extends CVS Deal, Is The Stock Fully Valued?"}, {"id":142820111,"url":"https://finnhub.io/api/news?id=4d051ea3729c9315fed5c13a05a00acf939426a9cf648456066898182aabec20","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"In October 2026, EPIC Pharmacies introduced a new wholesale distribution model naming McKesson as one of two primary partners, while McKesson separately announced an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032 across mail order, specialty, retail pharmacies, and distribution centers. Together, these moves highlight McKesson’s entrenched role in both large national chains and independent pharmacies, reinforcing its position...","category":"company","datetime":1791810884,"headline":"Does New CVS and EPIC Deals Reshape McKesson’s Pharmacy Distribution Narrative (MCK)?"}, {"id":142765387,"url":"https://finnhub.io/api/news?id=fd6a7f2f5da2fe7193f181a051c1c9f775a76cc192965320d7c5f49ddd378d57","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson Corporation (NYSE:MCK) is expanding its specialty healthcare operations through a $5.8 billion acquisition (including debt) of Option Care Health, Inc. (NASDAQ:OPCH), partnering with private equity firm Clayton, Dubilier & Rice to take the infusion-services provider private. Announced on October 6, the transaction values Option Care at $32.05 per share, representing a 37% premium to […]","category":"company","datetime":1791568158,"headline":"McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?"}, {"id":142727515,"url":"https://finnhub.io/api/news?id=a98edf85b5dcde01a756da2f0b29d3862357b7832cbb0676109ee8b36d807a77","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Suncoast Equity Management, an SEC-registered Investment Advisory (RIA), released its Q3 2026 investor letter for “U.S. Equity Large Cap Select Growth Strategy.” The letter can be downloaded here. The strategy advanced 4.2% after fees in Q3, compared to 2.3% for the S&P 500, marking a potential shift in market leadership. Despite lagging the S&P 500 […]","category":"company","datetime":1791467120,"headline":"How AI Adoption Could Supercharge McKesson (MCK)"}, {"id":142727516,"url":"https://finnhub.io/api/news?id=55ccab73fbd163f318aa22cfe3b1c4547b68a2799ac938aefa2edbab8639c750","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Here is how McKesson (MCK) and Avantor, Inc. (AVTR) have performed compared to their sector so far this year.","category":"company","datetime":1791463203,"headline":"Is McKesson (MCK) Outperforming Other Medical Stocks This Year?"}, {"id":142727517,"url":"https://finnhub.io/api/news?id=8949cd1235e6895465043289d3d02b3aaae3a0e95903c5cf7ef83568a1bfbbdb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?","category":"company","datetime":1791462604,"headline":"Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?"}, {"id":142701312,"url":"https://finnhub.io/api/news?id=3adf33948f3c7026eb2167648dbe3e9e0085e8385ca908c9f4560f9439790774","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"In the closing of the recent trading day, McKesson (MCK) stood at $910.33, denoting a -1.23% move from the preceding trading day.","category":"company","datetime":1791406803,"headline":"Here's Why McKesson (MCK) Fell More Than Broader Market"}
raw_source {"id":142838335,"url":"https://finnhub.io/api/news?id=0a1891b04ecff22fcd901545af45eb3854af9eacd60ae8b33d71629bd6f72792","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.","category":"company","datetime":1791875704,"headline":"3 Large-Cap Stocks to Keep an Eye On"}, {"id":142834486,"url":"https://finnhub.io/api/news?id=72ef390528f9357e6282d65e74062b0aaa8cbb4687effa371bd74cec6ec5d8c4","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2287251754/image_2287251754.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"MCK","summary":"McKesson stock is up 170% since 2022. Learn what’s driving growth, how recent M&A reshapes its portfolio, and if valuation limits upside.","category":"company","datetime":1791856719,"headline":"McKesson: Re-Rated Again Amidst Increased M&A Efforts"}, {"id":142825453,"url":"https://finnhub.io/api/news?id=5c26291ca92708763cb3875dc9ab591493dcebb54023a277eefc0cab5d20c7fa","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"AbbVie trades at a 40% valuation discount but faces revenue concentration risk, while Eli Lilly's cardiometabolic dominance commands a premium.","category":"company","datetime":1791849061,"headline":"AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?"}, {"id":142821758,"url":"https://finnhub.io/api/news?id=281a1eb6ee8f02bdc10783752dc8224a241eda5565d2625fab63ff404e67c0f6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson has been a powerful long term winner. With the share price now at US$938.84, the real question is whether the business can keep generating cash flows that line up with that kind of run. With a Discounted Cash Flow (DCF) view available, the focus turns squarely to what the current price implies about the money the company can return to shareholders over time. Over the past 5 years the stock has delivered a very large 379.8% return, which puts a lot of past optimism about McKesson's...","category":"company","datetime":1791818058,"headline":"McKesson (MCK) Stock Could Be 43% Undervalued Despite Its $1.4B Infusion Deal"}, {"id":142821757,"url":"https://finnhub.io/api/news?id=fbb0d7b782fa3b4aba78feb7fb325d6b48482c6a3eb9c1d87eb5906b0a671cef","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson (MCK) shares are in focus after the distributor reached an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032, reinforcing a long-running customer relationship. McKesson’s share price has been trending higher, with a 30-day share price return of 6.5% and a 90-day move of 16.9%. The 1-year total shareholder return of 22.5% and 5-year total shareholder return of about 3.8x suggest that recent contract wins and distribution...","category":"company","datetime":1791814584,"headline":"McKesson (MCK) Extends CVS Deal, Is The Stock Fully Valued?"}, {"id":142820111,"url":"https://finnhub.io/api/news?id=4d051ea3729c9315fed5c13a05a00acf939426a9cf648456066898182aabec20","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"In October 2026, EPIC Pharmacies introduced a new wholesale distribution model naming McKesson as one of two primary partners, while McKesson separately announced an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032 across mail order, specialty, retail pharmacies, and distribution centers. Together, these moves highlight McKesson’s entrenched role in both large national chains and independent pharmacies, reinforcing its position...","category":"company","datetime":1791810884,"headline":"Does New CVS and EPIC Deals Reshape McKesson’s Pharmacy Distribution Narrative (MCK)?"}, {"id":142765387,"url":"https://finnhub.io/api/news?id=fd6a7f2f5da2fe7193f181a051c1c9f775a76cc192965320d7c5f49ddd378d57","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson Corporation (NYSE:MCK) is expanding its specialty healthcare operations through a $5.8 billion acquisition (including debt) of Option Care Health, Inc. (NASDAQ:OPCH), partnering with private equity firm Clayton, Dubilier & Rice to take the infusion-services provider private. Announced on October 6, the transaction values Option Care at $32.05 per share, representing a 37% premium to […]","category":"company","datetime":1791568158,"headline":"McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?"}, {"id":142791266,"url":"https://finnhub.io/api/news?id=92546e8c535001a9c91c7067dcd42374edac84cda7c9007070044664e3809f11","image":"https://cdn.benzinga.com/files/images/story/2026/10/09/benzinga-deal-dispatch2.jpg?width=2048&height=1536","source":"Benzinga","related":"MCK","summary":"Major M&A deals this week include Viatris buys Pacira BioSciences, TowneBank acquires blueharbor, Energy Transfer buys Vacquero Midstream.","category":"company","datetime":1791558208,"headline":"Deal Dispatch: Uber Buys ezCater For $2.3B, Skydance Takes Over Warner Bros., True Food Kitchen Bankruptcy"}, {"id":142764221,"url":"https://finnhub.io/api/news?id=9498b5cb98287f1f74d6cf582c78552f57037c256cff903ea892d9090ca6cee7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Option Care Health (NasdaqGS:OPCH) faces shareholder investigations into its proposed sale to Clayton, Dubilier & Rice and McKesson Corporation. Several securities law firms announced probes into whether OPCH's board secured a fair price and process for investors. The legal reviews of the Clayton, Dubilier & Rice and McKesson deal only capture one slice of the Option Care Health story. Our analysis turns up 3 other big wins for Option Care Health as well. For a broader view on income...","category":"company","datetime":1791555360,"headline":"Option Care Health (OPCH) Faces Legal Review Of Its Proposed Takeover"}, {"id":142761782,"url":"https://finnhub.io/api/news?id=d2a3386c33af3eec6ee08a56e07e84c07a8081335d4b6fb1d7fd87dec46ff8b8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.","category":"company","datetime":1791551710,"headline":"1 Profitable Stock to Target This Week and 2 We Ignore"}, {"id":142761781,"url":"https://finnhub.io/api/news?id=d38ba1ffb6808cdfa5bc887612cb2d66457921416a2b8302e9702c841cb61e6e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.","category":"company","datetime":1791545403,"headline":"If You Invested $1000 in McKesson a Decade Ago, This is How Much It'd Be Worth Now"}, {"id":142754684,"url":"https://finnhub.io/api/news?id=49dcab10b88a6e931005c6a6946230572ef84117f1fee25d712af82f91297e10","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Option Care Health shares have jumped into focus after a sharp move higher and a US$5.8b buyout agreement, which raises a straightforward question for investors who care about valuation. Does the current price around the deal level make sense when you line it up against the earnings the business is generating? The stock gained 37.5% over the past week, which puts fresh pressure on the question of whether that surge is matched by the company’s earnings power. The agreed US$32.05 per share...","category":"company","datetime":1791537544,"headline":"Option Care Health (OPCH) Stock May Be Undervalued Despite The $5.8 Billion Buyout"}, {"id":142727515,"url":"https://finnhub.io/api/news?id=a98edf85b5dcde01a756da2f0b29d3862357b7832cbb0676109ee8b36d807a77","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Suncoast Equity Management, an SEC-registered Investment Advisory (RIA), released its Q3 2026 investor letter for “U.S. Equity Large Cap Select Growth Strategy.” The letter can be downloaded here. The strategy advanced 4.2% after fees in Q3, compared to 2.3% for the S&P 500, marking a potential shift in market leadership. Despite lagging the S&P 500 […]","category":"company","datetime":1791467120,"headline":"How AI Adoption Could Supercharge McKesson (MCK)"}, {"id":142727516,"url":"https://finnhub.io/api/news?id=55ccab73fbd163f318aa22cfe3b1c4547b68a2799ac938aefa2edbab8639c750","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Here is how McKesson (MCK) and Avantor, Inc. (AVTR) have performed compared to their sector so far this year.","category":"company","datetime":1791463203,"headline":"Is McKesson (MCK) Outperforming Other Medical Stocks This Year?"}, {"id":142727517,"url":"https://finnhub.io/api/news?id=8949cd1235e6895465043289d3d02b3aaae3a0e95903c5cf7ef83568a1bfbbdb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?","category":"company","datetime":1791462604,"headline":"Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?"}, {"id":142723435,"url":"https://finnhub.io/api/news?id=08bacb4f6c36d927c4722aa7437f7f46dee36fd9755b9cab015cc8d26f7cf7dc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"CVS Health (NYSE:CVS) has extended its long-term pharmaceutical distribution agreements with Cardinal Health and McKesson through 2032. The renewed contracts keep CVS Health as a major customer for both wholesalers, supporting its nationwide pharmacy and retail operations. Management highlighted that the agreements cover prescription drug distribution across CVS Health's retail pharmacies and other dispensing channels. The extension of CVS Health's Cardinal Health and McKesson distribution...","category":"company","datetime":1791454308,"headline":"What Does CVS Health (CVS) Gain From Extending Its Drug Distribution Deals To 2032?"}, {"id":142701312,"url":"https://finnhub.io/api/news?id=3adf33948f3c7026eb2167648dbe3e9e0085e8385ca908c9f4560f9439790774","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"In the closing of the recent trading day, McKesson (MCK) stood at $910.33, denoting a -1.23% move from the preceding trading day.","category":"company","datetime":1791406803,"headline":"Here's Why McKesson (MCK) Fell More Than Broader Market"}, {"id":142698754,"url":"https://finnhub.io/api/news?id=97fe2a1aa70ca741e595b1dcd4f7fce3262709170ae4b991bb80da8000604569","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson is taking 49% of Option Care as more complex infusion treatments shift to homes and outpatient sites.","category":"company","datetime":1791392820,"headline":"Option Care stock surges on McKesson's home-infusion bet"}, {"id":142699439,"url":"https://finnhub.io/api/news?id=33943256f1913b03b088d8cc24c4f218df31cfeb87c902b8455187d829366eca","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.","category":"company","datetime":1791387903,"headline":"Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think \"Yes\""}, {"id":142697269,"url":"https://finnhub.io/api/news?id=3d8cfb67f6a2d53bce707598bb58139f6b502400fbd2d209972924d0d2e39af7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson (NYSE:MCK) and Clayton Dubilier & Rice agreed to acquire Option Care Health in a US$5.8b transaction announced in 2026. The deal structure gives McKesson a significant minority stake in Option Care Health alongside private equity ownership. The acquisition expands McKesson's reach in specialty care, including home and outpatient medical infusion services outside traditional hospital settings. The Option Care Health acquisition and McKesson's new minority stake sit against a wider...","category":"company","datetime":1791382254,"headline":"What Is McKesson (MCK) Gaining From This $5.8 Billion Option Care Deal?"}, {"id":140420211,"url":"https://finnhub.io/api/news?id=c9045c53ac19ad80d94a07c2e8320fa134ac76c18ad5824d79898864952688d5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Intel downgraded, Marvell upgraded: Wall Street's top analyst calls","category":"company","datetime":1791381613,"headline":"Intel downgraded, Marvell upgraded: Wall Street's top analyst calls"}, {"id":142729390,"url":"https://finnhub.io/api/news?id=f9145b8bd4ccf7e7a3dbf4bf669e231db3f2901c8537fe2a2e8e5fc774a34eed","image":"","source":"Benzinga","related":"MCK","summary":"Leerink Partners analyst Michael Cherny maintains McKesson (NYSE:MCK) with a Outperform and raises the price target from $1030 to $1070.","category":"company","datetime":1791377873,"headline":"Leerink Partners Maintains Outperform on McKesson, Raises Price Target to $1070"}, {"id":142695045,"url":"https://finnhub.io/api/news?id=2ee09dc71cf8c644183588dab4c9bdacc799dc8aceb783716bb6818266e8ffc8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.","category":"company","datetime":1791374404,"headline":"Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?"}, {"id":142694026,"url":"https://finnhub.io/api/news?id=789a6ea7660236d7dcdecf3226305e350e88b1eb922d3bc106ebcc97cae78ac1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Option Care (OPCH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.","category":"company","datetime":1791370680,"headline":"Strength Seen in Option Care (OPCH): Can Its 32.7% Jump Turn into More Strength?"}, {"id":142686463,"url":"https://finnhub.io/api/news?id=955f8a446297ab01638c6f13cc6db72490be0a5260f6afc2f1b0f72095be05cc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Companies In The Article Are:AMD,CEG,GOOG,OPCH,MCK and VST","category":"company","datetime":1791359460,"headline":"Company News for Oct 7, 2026"}, {"id":142694607,"url":"https://finnhub.io/api/news?id=7a709be9f678e2f04f5132aa38eb3e0a155441b33f121af420628e5065bf515b","image":"https://cdn.benzinga.com/files/images/story/2026/10/07/Stock-Market-Chart-With-Green-Candlestic.jpg?width=2048&height=1536","source":"Benzinga","related":"MCK","summary":"AMD, CEG, MRVL, OPCH, FCEL were among the stocks seen trending on Tuesday, Oct. 6, 2026.","category":"company","datetime":1791321874,"headline":"AMD, Constellation Energy, Marvell Technology, Option Care Health and FuelCell Energy: Why These 5 Stocks Are on Investors' Radars Today"}, {"id":142667801,"url":"https://finnhub.io/api/news?id=9a8c24566e9da0f05dac10b4398012d1985a482bea3ab0f26d4c955aa9ee2c33","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Healthcare stocks were mixed late Tuesday afternoon, with the NYSE Healthcare Index up 0.2% and the","category":"company","datetime":1791316298,"headline":"Sector Update: Healthcare Stocks Mixed Late Afternoon"}, {"id":142667802,"url":"https://finnhub.io/api/news?id=6b1de2f1930433751d01771318b68e4fcccf25d36d48eaaa5b9efd3d62504d66","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson Corporation (NYSE:MCK) was trading at around $916 on October 5, up 1.53% on the day and 21.72% over twelve months. The company collected $410.98 billion in revenue and kept $4.59 billion, a net margin of 1.12%. Its book value per share is negative $36.55. A business with almost no margin and no equity is […]","category":"company","datetime":1791315976,"headline":"McKesson (MCK) Earns 1.12% on Sales and Has No Equity Left. How Does That Work?"}, {"id":142667803,"url":"https://finnhub.io/api/news?id=835a82886c5231beb0f2ef48f984cfb2d74676f90c16dd4a93a1cb34ade27720","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Option Care Health Inc. (NASDAQ:OPCH) soared by as much as 33 percent on Tuesday to $31.11 apiece following news that it is merging with Clayson, Dubilier, & Rice LLC (CD&R) and McKesson Corp. for $5.8 billion. In a joint statement, the firms said that they entered into a definitive agreement under which they will acquire […]","category":"company","datetime":1791315928,"headline":"Option Care Health (OPCH) Rockets as CD&R, McKesson Table 37% Premium Bid"}, {"id":142667615,"url":"https://finnhub.io/api/news?id=1c5aa018d0e0c30ee0f8e265f88af23039a2252a01432476bbd1c276a7dfe4cc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"The provider of home and alternate site infusion services is being acquired.","category":"company","datetime":1791313007,"headline":"Why Option Care Health Stock Skyrocketed on Tuesday"}, {"id":142666913,"url":"https://finnhub.io/api/news?id=25cca564f16bb177370a939e8f4b00c88ad3cb0d33d77bc83666d601d7cab63d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Healthcare stocks were mixed Tuesday afternoon, with the NYSE Healthcare Index up 0.1% and the State","category":"company","datetime":1791308794,"headline":"Sector Update: Healthcare Stocks Mixed Tuesday Afternoon"}, {"id":142666914,"url":"https://finnhub.io/api/news?id=a9fd3b17d2f3ee6497fef7c9b418df133adea1c4eb5a7709915545a87ba8e70e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Drug distributor McKesson (MCK) and private investment firm Clayton Dubilier & Rice agreed to acquir","category":"company","datetime":1791307805,"headline":"McKesson, CD&R to Buy Option Care Health in $5.8 Billion Deal"}, {"id":142666915,"url":"https://finnhub.io/api/news?id=92b0ec64118436fb85afc19f22f5f9013bcb2596b8d4c0d1cd3ec514dafddf0f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Option Health Care shares skyrocketed Tuesday after McKesson and CD&R agreed to buy the infusion services company for $5.8 billion.","category":"company","datetime":1791302685,"headline":"Option Health Care Skyrockets On $5.8 Billion McKesson, CD&R Takeover"}, {"id":142695310,"url":"https://finnhub.io/api/news?id=414fc4d6fffa16bbaf44e711859053c69461f20865ed804f26d7cc01fedd9dde","image":"https://cdn.benzinga.com/files/images/story/2026/10/06/Medical-Business-Handshake.jpg?width=2048&height=1536","source":"Benzinga","related":"MCK","summary":"Option Care Health agreed to a $5.8B buyout by CD&R and McKesson at $32.05 per share, pending shareholder and regulatory approvals.","category":"company","datetime":1791300247,"headline":"Option Care Stock Trades Below McKesson's Deal Price — Here's the Spread"}, {"id":142665738,"url":"https://finnhub.io/api/news?id=c7f003a3d0774a1a1ccc0f0b92bddd2b1016b67d45817f6cfa69d5ac60037acc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Option Care Health has agreed to be acquired by CD&R and McKesson for $32. 05 per share in cash, representing approximately $5.","category":"company","datetime":1791298111,"headline":"Option Care Health Agrees to $5.8 Billion Acquisition by CD&R and McKesson at $32.05 Per Share"}, {"id":142665445,"url":"https://finnhub.io/api/news?id=7d333eddfc3e8ce35da9d45ff3aa7acd138c244bd6355a80e4cba364c60f2695","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"On this episode of Stock Movers: - Option Care Health (OPCH) shares jumped after the Financial Times reports that McKesson and PE firm Clayton Dubilier & Rice are closing in on a deal to buy the provider of medical infusion services, that would value the business at more than $5b including debt. - Constellation Energy (CEG) shares are higher on news Google and Constellation Energy announced a long-term deal to bring 890 MW of new nuclear capacity on the PJM grid in Illinois, Pennsylvania and New Jersey. - SpaceX (SPCX) shares are the most actively traded in the premarket as NASA is close to announcing a bulk purchase of rocket launches to fuel its $30 billion drive to build a permanent base on the moon for humans to live and work. It also made Elon Musk a trillionaire once again.","category":"company","datetime":1791297662,"headline":"Google, Constellation Energy Deal; SpaceX Rises on Talks with NASA | Stock Movers"}, {"id":142662955,"url":"https://finnhub.io/api/news?id=a79264aca14b600f8fd73874c113158161ffe44d0b27110d763f44af3d82f8bc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Eli Lilly's revenue surged 44.7% in 2025, but Novo Nordisk trades at less than a quarter of its valuation multiple, a stark contrast that reshapes the risk-reward calculus.","category":"company","datetime":1791293401,"headline":"Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026?"}, {"id":142663226,"url":"https://finnhub.io/api/news?id=7e9ecf5c601a9fbf6b67264ae2ca8c8397a55179a12e2c766b21164e6032b182","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Key TakeawaysOption Care Health shares jumped 33% after CD&R and McKesson agreed to buy the company for $32. 05 per share in cash, about $5.","category":"company","datetime":1791292972,"headline":"Option Care Health Soars 33% on $5.8 Billion Buyout by CD&R and McKesson: “A Great Outcome”"}, {"id":142665739,"url":"https://finnhub.io/api/news?id=9452824b7a657f2a87bd7be9d69481efcd1885609ba6f7d580da29bc398767ac","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Mckesson Corp (NYSE:MCK), the US healthcare services and drug distribution company, and Clayton Dubilier & Rice (CD&R), the private investment firm, have agreed to acquire Option Care Health (NASDAQ:OPCH) for approximately $5.8 billion. The buyers will pay $32.05 a share for Option...","category":"company","datetime":1791290220,"headline":"McKesson and CD&R agree to acquire Option Care Health for $5.8 billion"}, {"id":142663228,"url":"https://finnhub.io/api/news?id=456fa693e4637a9a3173ec33fb17884700b5b455bda2294076068755caf4a96a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"NEW YORK & IRVING, Texas & BANNOCKBURN, Ill., October 06, 2026--CD&R, McKesson Corporation (NYSE: MCK) (\"McKesson\"), and Option Care Health, Inc. (Nasdaq: OPCH) (\"Option Care Health\") announced today that they have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health, an independent provider of home and alternate site infusion services, for $32.05 per share, reflecting a total enterprise value of approximately $5.8 billion. At the closing of the tran","category":"company","datetime":1791288000,"headline":"CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health"}, {"id":142661963,"url":"https://finnhub.io/api/news?id=fa72d417c9aabb88ae86648a050b7cdf42c3205e2d766a2253ff7a7a88f4be7e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"OPCH and CEG rallied on potential multibillion-dollar agreements, while CTVA gained after a JPMorgan upgrade and NKE fell on a sharp Berenberg downgrade.","category":"company","datetime":1791285179,"headline":"Premarket Movers: OPCH, CEG Stocks Jump On Buyout Talks, Nuclear Deal – NKE Slides On ‘Sell’ Rating"}, {"id":142664435,"url":"https://finnhub.io/api/news?id=9a25394c93cdf8e0a5a1f8c7436bfe7478f0424b4181fc6ee3b15e541506707c","image":"https://cdn.benzinga.com/files/images/story/2026/10/06/Mckesson-Office-Building-In-San-Francisc.jpg?width=2048&height=1536","source":"Benzinga","related":"MCK","summary":"CD&R and McKesson acquire Option Care Health in a $5.8 billion transaction at $32.05 per share as analysts assess acquisition terms.","category":"company","datetime":1791283233,"headline":"McKesson Takes A Stake In Option Care — With An Option On The Rest"}, {"id":142658670,"url":"https://finnhub.io/api/news?id=a196c9329f5ee48f0734539e2e91f043eb2527b2508de76598e187b378d12cb1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"(Updates with the stock move in the headline and the second paragraph.) Option Care Health (OPCH)","category":"company","datetime":1791281539,"headline":"Update: Market Chatter: Option Care Health's Shares Soar Pre-Bell as $5 Billion Acquisition Talks With Suitors Hit Advanced Stage"}, {"id":142664262,"url":"https://finnhub.io/api/news?id=99a73bb1a3a2114d2317328be02224642ad7d6142a5946c712725f2d1d39c779","image":"","source":"Benzinga","related":"MCK","summary":"CD&R, McKesson Corporation (NYSE: MCK) ("McKesson"), and Option Care Health, Inc. (NASDAQ:OPCH) ("Option Care Health") announced today that they have entered into a definitive agreement, under which","category":"company","datetime":1791274376,"headline":"CD&R, McKesson Agree To Acquire Option Care Health For $32.05 Per share"}, {"id":142662208,"url":"https://finnhub.io/api/news?id=17dd429d423e0a7cc54685abed73252a2c704b9d2624f2650c57a37afcd780f1","image":"https://static.seekingalpha.com/uploads/2026/10/4/saupload_needle_in_haystack.png","source":"SeekingAlpha","related":"MCK","summary":"In our monthly Rare Stock Picks series, we're highlighting September 2026 investment picks. Click here for the list of September 2026 Buy recommendations.","category":"company","datetime":1791273600,"headline":"Rare Stock Picks In September 2026 - From 21 Discerning Analysts"}, {"id":142666426,"url":"https://finnhub.io/api/news?id=9d934b87a25170b8cd17708c6faaf587e648ac7ff8c4001aeb7ba41155af950c","image":"https://image.cnbcfm.com/api/v1/image/108084881-1736521567387-gettyimages-2192400361-BIZ-CONSTELLATION-CALPINE-BZ.jpeg?v=1744213721&w=1920&h=1080","source":"CNBC","related":"MCK","summary":"These are the stocks posting the largest moves in early trading.","category":"company","datetime":1791273050,"headline":"Stocks making the biggest moves premarket: Constellation Energy, Option Care Health, Lennar, P&G and more"}, {"id":142651138,"url":"https://finnhub.io/api/news?id=9114d67e717241f98a92cb00623d6fbd96d7c2d444e8304ade380578530a6046","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"AMSTERDAM, October 06, 2026--Hadrian, the agentic AI offensive security platform, today announced a $40 million funding round co-led by Forgepoint Capital International and SmartFin, with participation from existing investors HV Capital, Motive Partners, Picus Capital and Oetker Ventures. The backing brings total funding to $65M and will fund expansion across EMEA and the U.S. and deepen investment in Hadrian's engineering and research teams.","category":"company","datetime":1791270000,"headline":"Hadrian Raises $40M to Tackle the AI Hacking Cyber Security Crisis"}, {"id":142639807,"url":"https://finnhub.io/api/news?id=9ab2f9bc055160266f8118ea2253875ed0f7f2fd526d6abf6433ed4f78a80f8a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Option Care is in advanced talks after a joint bid from McKesson and private equity firm Clayton Dubilier & Rice, FT reported.","category":"company","datetime":1791239257,"headline":"OPCH Stock Soars 22% After-Hours On $5B McKesson Buyout Talks"}, {"id":142639332,"url":"https://finnhub.io/api/news?id=f32078a3fdc62bf5dac28f5c3633d2960c9d16a4fa89c08061ee56c0b0350f7b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"A deal would value the infusion provider at more than $5 billion.","category":"company","datetime":1791234960,"headline":"Report of Possible $5 Billion Takeover Bid Sends Option Care Health Stock Higher"}, {"id":142639221,"url":"https://finnhub.io/api/news?id=5d550c1eea6627c4239e7e0734fe6356ecd9cb364463c68f6b2ce3d6fc895d48","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Investing.com -- Shares of Option Care Health (NASDAQ: OPCH) surged 22% in after-hours trading on Monday following a Financial Times report that healthcare giant McKesson and private equity firm Clayton Dubilier & Rice (CD&R) are in advanced talks to acquire the infusion services provider. The potential transaction is expected to value the company at more than $5 billion, including debt.","category":"company","datetime":1791233087,"headline":"Option Care Health surges 22% on report of $5 billion takeover by McKesson, CD&R"}, {"id":142664263,"url":"https://finnhub.io/api/news?id=1b0207b584fa51908704d2ed58a42c554e94e0cb7f6fb57e9d65c4e3b3b4184b","image":"https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_1.jpg?width=2048&height=1536","source":"Benzinga","related":"MCK","summary":"McKesson (NYSE:MCK) has outperformed the market over the past 20 years by 6.56% on an annualized basis producing an average annual return of 15.64%. Currently, McKesson has a market capitalization of $106.73 billion.","category":"company","datetime":1791229517,"headline":"Here's How Much $1000 Invested In McKesson 20 Years Ago Would Be Worth Today"}, {"id":142636689,"url":"https://finnhub.io/api/news?id=fb56f6ad3dd10485a7f4e1b6c50af21909d14625d8bbab09f52060bc2db42aac","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"One Number: $7.2 Million in Revenue Per Employee NVIDIA (NASDAQ:NVDA) now brings in about $7.2 million in revenue for each person on its payroll. That figure comes from $302.97 billion in trailing 12-month revenue across roughly 42,000 employees, and it is 5.8x higher than it was three years ago. The revenue figure gets the attention, […]","category":"company","datetime":1791215517,"headline":"Nvidia Generates $7.2 Million per Employee, Up 500% in 3 Years. This Number Is Even More Astounding."}, {"id":142634318,"url":"https://finnhub.io/api/news?id=0f791ab75f6474bac4337db895517f5d04520e577a02ed846ff21b5c8bd44ebe","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"IRVING, Texas, October 05, 2026--InspiroGene™ by McKesson today announced the publication of its third annual 2026 Cell and Gene Therapy Report.","category":"company","datetime":1791198000,"headline":"New 2026 Cell and Gene Therapy Report Charts the Path from Scientific Progress to Patient Access"}, {"id":142624185,"url":"https://finnhub.io/api/news?id=773d3787e684fba498bba3b49094c209329c0e46fcca5973e7c495eb6d0c1b89","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"One offers a more affordable entry point while the other boasts some of the highest profit margins in the sector. The choice comes down to whether you prioritize income stability or growth potential.","category":"company","datetime":1791124497,"headline":"Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?"}, {"id":142601554,"url":"https://finnhub.io/api/news?id=8f6872a09480f4ec64796fb827f731e470b37cb5e16d2cfb3fdb8bc48637fc73","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Bond yields have surged to levels not seen in decades, mortgage rates now sit above 7% and big institutional players are pulling back from Treasuries. That combination is reshaping how investors think about risk, cash flow and balance sheet strength. This piece walks through three large cap stocks exposed to these rate moves, all filtered for solid free cash flow, to help you judge which stories might deserve a closer look now. The three examples below are only a sample set, and the full...","category":"company","datetime":1791004184,"headline":"3 Cash Rich US Stocks Investors Are Watching As Bond Yields Stay High"}, {"id":142588574,"url":"https://finnhub.io/api/news?id=84ccaec2825b0d28abb6caaf6d3fe52e576a7aa1808c568dab8b141291eaad47","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Medical-dental supplies see durable demand from specialty care, AI and aging trends, with McKesson and peers navigating tariffs and inflation.","category":"company","datetime":1790944860,"headline":"Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex"}, {"id":142579898,"url":"https://finnhub.io/api/news?id=dfb24a232bcd5528c08c4b29ac1b774ea3ccb4016e22070e2d17a4961607b3f2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Companies In The News Are: ACN, AYI, MCK, PRGS.","category":"company","datetime":1790925600,"headline":"Company News for Oct 2, 2026"}, {"id":142564194,"url":"https://finnhub.io/api/news?id=99afa9069d93664d93769b266460cdde5fca26574903426f9129704188e98e59","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"The company extended its existing partnership with a major pharmacy chain.","category":"company","datetime":1790899181,"headline":"Why McKesson Stock Soared More Than 5% Higher Today"}, {"id":142563714,"url":"https://finnhub.io/api/news?id=e98e6cb8cdda4ddef333d043a63b0f58a5549656408252b35331ef9926a27d67","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"AbbVie boasts stronger revenue growth and free cash flow, while Bristol Myers Squibb trades at half the valuation with nearly double the profit margin.","category":"company","datetime":1790894462,"headline":"AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?"}, {"id":142563821,"url":"https://finnhub.io/api/news?id=78fc971fe61f574792be360b18b4773919e6ef619c3f66fee267816df3d9ab21","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Shares of healthcare distributor and services company McKesson (NYSE:MCK) jumped 4.4% in the afternoon session after the company reached an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032.","category":"company","datetime":1790892787,"headline":"Why McKesson (MCK) Stock Is Trading Up Today"}, {"id":142560293,"url":"https://finnhub.io/api/news?id=b20e08d06594043d73774dff90800dc69a3fc3d1ae58095ba1758b392220c4e2","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"MCK","summary":"Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.","category":"company","datetime":1790872502,"headline":"Which S&P500 stocks are moving on Thursday?"}, {"id":142560961,"url":"https://finnhub.io/api/news?id=8c29bad414b888ad54769f6de437407f88dbac1694c85437f21feccb43df9fce","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Bond yields hit their highest level in two decades, pressuring blue chip dividend stocks and weighing on the broader market, today, Oct. 1, 2026.","category":"company","datetime":1790871633,"headline":"Stock Market Midday, Oct. 1: Stocks Edge Lower as Treasury Yields Surge to 24-Year High"}, {"id":142559894,"url":"https://finnhub.io/api/news?id=2d422b2dc387e4525b846d85e51029105cafeb0b86467b57b8d2a7a1ad538a50","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Investing.com -- McKesson Corporation (NYSE:MCK) shares rose 4.4% Thursday following the announcement of an extended pharmaceutical distribution agreement with CVS Health through June 2032.","category":"company","datetime":1790867094,"headline":"McKesson extends CVS deal; shares rise"}, {"id":142559043,"url":"https://finnhub.io/api/news?id=59a342f752939553f2e3d8e29e06764b348e36d80fb4ad00f938a1f983b96856","image":"https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp","source":"ChartMill","related":"MCK","summary":"Looking for the S&P500 stocks that are experiencing notable gaps on Thursday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.","category":"company","datetime":1790865302,"headline":"These S&P500 stocks are gapping in today's session"}, {"id":142557887,"url":"https://finnhub.io/api/news?id=4da254ec7e298a4369c4d7487af3ab3e23bac54bf00a3b6c00fcefe111f00e57","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"RICHMOND, Va., October 01, 2026--EPIC Pharmacies, Inc. (EPIC Rx), a nationwide buying group dedicated to supporting and empowering independent pharmacies, today announced an expanded approach to wholesale distribution that provides member pharmacies with greater choice and flexibility in how they purchase medications. As a champion of pharmacy independence, EPIC Rx is putting greater control in the hands of pharmacy owners and operators, allowing them to select the wholesale partner that best al","category":"company","datetime":1790859600,"headline":"EPIC Rx Introduces New Wholesale Distribution Options for Member Pharmacies"}, {"id":142557888,"url":"https://finnhub.io/api/news?id=e5de8a290d534514dd1059d53da492c4f3d6c0ccb367623167bd969120f8e626","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"IRVING, Texas, October 01, 2026--McKesson Corporation (NYSE: MCK) announced today that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies, retail pharmacies, and distribution centers through June 2032.","category":"company","datetime":1790856180,"headline":"McKesson Corporation Extends Pharmaceutical Distribution Agreement with CVS Health"}, {"id":142588192,"url":"https://finnhub.io/api/news?id=a5de3a7978cd533cf49a7a5e0e5decbfe12ed24021ec5e06c8d8665b7e74714a","image":"https://cdn.benzinga.com/files/images/story/2026/10/01/Chandler--Arizona---April-08-2023cvs-Hea.jpg?width=2048&height=1536","source":"Benzinga","related":"MCK","summary":"Cardinal Health and McKesson extend drug distribution deals with CVS Health through June 2032, reaffirming FY2027 adjusted earnings guidance.","category":"company","datetime":1790855987,"headline":"Cardinal Health, McKesson Double Down on CVS Deals Through 2032"}, {"id":142557889,"url":"https://finnhub.io/api/news?id=6aef2f6be077d7cadc16d7f461abb00cb9e3ac60b722a6e258a13f9e2397edee","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.","category":"company","datetime":1790855760,"headline":"5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve"}, {"id":142559134,"url":"https://finnhub.io/api/news?id=03841322c4307650d2508ff35854a44d31563f24911a6c231a3e7804ecb9c8c7","image":"","source":"Benzinga","related":"MCK","summary":"McKesson Corporation (NYSE: MCK) announced today it is reaffirming its fiscal year 2027 adjusted EPS guidance of $44.20 to $45.00 and its long-term adjusted EPS growth rate of 13% to 16%. Further updates will be","category":"company","datetime":1790841949,"headline":"McKesson Reiterates FY27 Adjusted EPS Outlook Range Of $44.20 To $45"}, {"id":142524984,"url":"https://finnhub.io/api/news?id=3087ab39040439f1d4ce75aaf55c3147841fe9b80c9fa54e439fb603179ce87e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson (MCK) reached $853.81 at the closing of the latest trading day, reflecting a -1.27% change compared to its last close.","category":"company","datetime":1790802004,"headline":"McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to Know"}, {"id":142522612,"url":"https://finnhub.io/api/news?id=39c8b0d65d016661fc240daa4dc5d5c622c60cf374cedbb1865d36d02d4b09f9","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2233434722/image_2233434722.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"MCK","summary":"Cardinal Health remains a Buy, driven by robust FY2026 results, strong cash flow, and credible FY2027 guidance. Read more on CAH stock here.","category":"company","datetime":1790780492,"headline":"Cardinal Health: I'm Still Buying After Checking The Numbers"}, {"id":142500485,"url":"https://finnhub.io/api/news?id=2e4cca44897a22fa2022d1bef94f65c51be5e651759eb8ed851cbfaf5475f9c5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson's specialty distribution, oncology and GLP-1 growth are driving earnings, while drug pricing, margin pressure and policy uncertainty pose challenges.","category":"company","datetime":1790704620,"headline":"Here's Why You Should Retain McKesson Stock in Your Portfolio for Now"}, {"id":142426691,"url":"https://finnhub.io/api/news?id=68c6d99ecb3945426214e324f0415ce3bfad6b187bddbedeb0207483edb9d72e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"AbbVie bets on pipeline diversification amid patent cliffs, while J&J's higher profitability masks litigation risks, a choice between growth ambition and defensive stability.","category":"company","datetime":1790378161,"headline":"AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?"}, {"id":142432371,"url":"https://finnhub.io/api/news?id=403589f5a28b768b40e6b9e54ab5a5d2aa8836e772aecee6e6c1fa8830560d81","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"MCK","summary":"Get the weekly summary of dividend changes for Dividend Champions, Contenders & Challengers, plus upcoming ex-dividend and pay dates.","category":"company","datetime":1790377479,"headline":"Dividend Champion, Contender, And Challenger Highlights: Week September 27"}, {"id":142426107,"url":"https://finnhub.io/api/news?id=3c443fa180b195a06f52ced8a8b5d4a24a692b809dd175762819f3d8ae4b1d19","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"AbbVie pivots toward newer immunology drugs while Pfizer leans on acquisitions to offset pandemic decline, but their financial profiles and valuations tell starkly different stories.","category":"company","datetime":1790371321,"headline":"AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026?"}, {"id":142425604,"url":"https://finnhub.io/api/news?id=878962ab226368893bd0e3a112a0136b824ea77667f2813f3b7b015570b4a55b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson (MCK) is back in focus after its share price dipped 1.2%, trailing the broader market, as investors weigh mixed earnings estimates against the company’s raised full-year adjusted EPS guidance and specialty-led healthcare footprint. Recent trading has been choppy for McKesson, with the share price slipping 3.95% over the past 30 days even after a 13.86% 90 day share price return and a 5.58% share price gain year to date. That near term hesitation sits against a much stronger backdrop,...","category":"company","datetime":1790359848,"headline":"McKesson (MCK) Lifted Its Guidance, Is The Stock Still 11% Undervalued?"}, {"id":142386749,"url":"https://finnhub.io/api/news?id=a527e44c28e4d2901c54177a49412223ada2e94c09864f8c6483e6026a3335f0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Novo Nordisk trades at a steep discount on earnings and sales, while AbbVie grapples with patent cliffs and pricing pressure, but profitability tells a different story.","category":"company","datetime":1790284741,"headline":"AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026?"}, {"id":142386737,"url":"https://finnhub.io/api/news?id=8eb972c08a04133027eb920e3fc3b121b93a21bf2259240dd130d95008f10fd5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"AbbVie leans on legacy income and portfolio transition, while Eli Lilly rides explosive growth in weight-loss drugs, but at vastly different valuations.","category":"company","datetime":1790281321,"headline":"AbbVie vs. Eli Lilly: Which Star Pharma Stock Is a Better Buy in 2026?"}, {"id":142384809,"url":"https://finnhub.io/api/news?id=0d14123a814a7697551c1b9721cb42f411a5c2f323385dcb61a4efd61c8eba17","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"CAH's specialty-led growth, stronger EPS outlook and improving estimate momentum set up a compelling case against MCK.","category":"company","datetime":1790264700,"headline":"Cardinal Health vs. McKesson: Which Healthcare Stock Is Better?"}, {"id":142422371,"url":"https://finnhub.io/api/news?id=2f207591964d54e3b97e4b59682480e0b1a5ab5aa1bb6648b9d6841d6b017654","image":"https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_4.jpg?width=2048&height=1536","source":"Benzinga","related":"MCK","summary":"McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 22.21% on an annualized basis producing an average annual return of 34.23%. Currently, McKesson has a market capitalization of $102.91 billion.","category":"company","datetime":1790253034,"headline":"Here’s How Much You Would Have Made Owning McKesson Stock In The Last 5 Years"}, {"id":142366009,"url":"https://finnhub.io/api/news?id=6c645c81b5d6816582aa97b3f057edf088458209713d2f7c8547976c7d4cc6a1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"The latest trading day saw McKesson (MCK) settling at $880.5, representing a -1.2% change from its previous close.","category":"company","datetime":1790200803,"headline":"Why McKesson (MCK) Dipped More Than Broader Market Today"}, {"id":142359800,"url":"https://finnhub.io/api/news?id=21e8d0e8b0fadadc3e3fa8b51bd2ad4e5bbe2da4679cc19d5fb4855b1a5b0ec9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.","category":"company","datetime":1790168407,"headline":"McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know"}, {"id":142359801,"url":"https://finnhub.io/api/news?id=e2eeb3460907b49da59df8b243b36bf8808d025644ac999e210fc49d00082d55","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"IRVING, Texas, September 23, 2026--McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2027 financial results after market close on Wednesday, November 4, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.","category":"company","datetime":1790164800,"headline":"McKesson Corporation Announces Second Quarter Fiscal 2027 Earnings Release Date"}, {"id":142337859,"url":"https://finnhub.io/api/news?id=5e90da72b9445f8f269fe769a77eee231cb102829bca91c22fcabee80a02ffe0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"CAH is expanding its MSO strategy across specialty care, with Solaris and broader services aimed at scaling physician networks.","category":"company","datetime":1790083920,"headline":"Can CAH's MSO Expansion Unlock Growth in Specialty Care Delivery?"}, {"id":142315583,"url":"https://finnhub.io/api/news?id=eabc3a29647ff9263112fd7e84226baafd3f2b824601a72d0d96d7ab23b38c35","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Since March 2026, McKesson has been in a holding pattern, floating around $872.99. The stock also fell short of the S&P 500’s 16.4% gain during that period.","category":"company","datetime":1790021665,"headline":"3 Reasons MCK Has Explosive Upside Potential"}, {"id":142258086,"url":"https://finnhub.io/api/news?id=609ac00b5cd43a3cdf9674d3ec513292d7a9ffa17a752ca1e6ecd17075ce8b5f","image":"https://image.cnbcfm.com/api/v1/image/108364583-17896719001789671898-48440813815-1080pnbcnews.jpg?v=1789671899&w=1920&h=1080","source":"CNBC","related":"MCK","summary":"Skyler Weinand, Regan Capital CIO, joins 'Power Lunch' to discuss the best stocks for a sustained rate hike cycle.","category":"company","datetime":1789657793,"headline":"Really like Northrop Grumman as a value play, says Regan Capital's Skyler Weinand"}, {"id":142220724,"url":"https://finnhub.io/api/news?id=825ed465d57b9b84b5b396a439153daf594d2d7e37c3d9353a2aed5c3fb912fd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.","category":"company","datetime":1789639817,"headline":"1 Unpopular Stock That Deserves Some Love and 2 We Turn Down"}, {"id":142197211,"url":"https://finnhub.io/api/news?id=fa5c0c94bd0a3b0d0eb0b39a7c41bebafa4e33cde64a461c0074cfb715c4f818","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” second-quarter 2026 investor letter. The letter can be downloaded here. The second quarter reflected a sharp shift from geopolitical uncertainty and oil market volatility to a powerful equity rally led by semiconductor companies. Despite the broader market strength, the Fund declined […]","category":"company","datetime":1789571094,"headline":"Alluvium Raised Its McKesson (MCK) Stake as Long-Term Growth Expectations Remain Strong"}, {"id":142158577,"url":"https://finnhub.io/api/news?id=df523848265bf481e0a7f7ef18142b6d13d71c1fffdfc497171396fd88af6155","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson recently raised its full-year EPS guidance, projecting approximately 13%–15% growth (15%–17% excluding certain prior-year items), and outlined plans to rebrand its Medical-Surgical unit as Wellverse with a potential IPO targeted for the second half of 2027, alongside a pending acquisition of Precision Medicine Group to expand oncology and biopharma-services capabilities, subject to regulatory approval. This combination of upgraded earnings expectations, portfolio reshaping around...","category":"company","datetime":1789463504,"headline":"Did McKesson’s (MCK) EPS Hike and Oncology Push Just Redefine Its Investment Narrative?"}, {"id":142139308,"url":"https://finnhub.io/api/news?id=8f218e6f7b910d123201ac23fb800ce70f363d4a3dd35a78f17158dcc3292a09","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"AbbVie is profitable, growing, and paying a rising dividend. CRISPR is burning cash in pursuit of a gene-editing breakthrough that could reshape medicine.","category":"company","datetime":1789398055,"headline":"AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?"}, {"id":142137295,"url":"https://finnhub.io/api/news?id=dcc4b288ae6e93f54675969bd802a9ab516ad006a056529faa42c98979a51c3e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson (NYSE:MCK) executives said the company’s first-quarter performance supported a higher full-year earnings outlook, citing broad-based growth across its North American Pharmaceutical, Oncology & Multispecialty and Prescription Technology Solutions businesses. Speaking at the Morgan Stanl","category":"company","datetime":1789390938,"headline":"McKesson Raises Outlook, Eyes Oncology Growth With Precision Medicine Deal"}, {"id":142135993,"url":"https://finnhub.io/api/news?id=da1e88d3e7f35b8059dfd20fd97ed62f63419a669479637d7a9f61c48ee2f6bc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Amgen trades at a cheaper valuation but carries higher leverage, while Vertex boasts pristine finances and 32% net margins, a classic trade-off between value and quality.","category":"company","datetime":1789383825,"headline":"Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?"}, {"id":142138058,"url":"https://finnhub.io/api/news?id=4d90149136c5f41327c113354fdc5242c1583fff9332db691b343e5ab0a73218","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"MCK","summary":"McKesson Corporation (MCK) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 7:45 AM EDTCompany ParticipantsBrian Tyler - CEO &...","category":"company","datetime":1789381900,"headline":"McKesson Corporation (MCK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript"}, {"id":142163085,"url":"https://finnhub.io/api/news?id=ed034ae5db6b4ec4061bdcecf7d571dc60aa47a4e0212d5e8b8b81b1993087e9","image":"","source":"Benzinga","related":"MCK","summary":"RBC Capital analyst Ryan Halsted reiterates McKesson (NYSE:MCK) with a Sector Perform and maintains $845 price target.","category":"company","datetime":1789379722,"headline":"RBC Capital Reiterates Sector Perform on McKesson, Maintains $845 Price Target"}
data_source finnhub_news_keyword_model
article_count 8
negative_hits 0
positive_hits 1
recomputed_at_score true
sentiment_score_raw 0.3
source_article_count 94
discarded_article_count 73
sentimentPoints 3

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.4 5/110 68% 3.4
資金流 13.2 20/110 66% 13.2
市場環境 10.2 15/110 68% 10.2
催化劑 2 20/110 10% 2
風險管理 6.8 10/110 68% 6.8
技術信號 20.8 30/110 69.33% 20.8
情緒分析 3 10/110 30% 3

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 18/50
ret_5d 0.0436
max_score 50
max_total 50
raw_total 18
vcp_bonus 0
vol_ratio 0.893
ret_points 8
vol_points 0
range_ratio 0.6713
volat_points 0
day_range_pct 0.0159
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 8
partial_history false
pullback_points 0
breakout_vol_bonus 0
first_breakout_20d true
return_window_days 5
first_breakout_bonus 2
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 2.506
turnoverUsdM 715.2463
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.MCK
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 913.6704

strength_details

ma_score 2
atr_score 2
rsi_score 0.5
macd_score 3
volume_score 1
market_adjustment 1
risk_reward_ratio 1.1
stop_loss_percent 5
take_profit_price 1015.3123
target_multiplier 1.9
technical_strength 1.75
take_profit_percent 5.6
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.012
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.4/5分
資金流分析總分: 13.2/20分
市場環境分析總分: 10.2/15分
催化劑分析: 2/20分
風險管理總分: 6.8/10分
技術信號分析總分: 20.8/30分
情緒分析: 3/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 85.71
atr
atr 24.1048
rule ATR / current price; lower volatility scores higher
score 6
atr_pct 2.51
cci
rule Cursor_18.24 CCI bands
level 超買或超賣風險
score 2
value 174.75
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.0221
kdj
d 81.28
j 106.62
k 89.73
rule Cursor_18.24 K/D cross
score 4
signal 金叉
mfi
rule Cursor_18.24 MFI bands
level 平衡
score 6
value 55.72
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 10
trend 強流入
value -3416908
recentSlope 515979.2
previousSlope -389040
rsi
value 73.32
sar
rule Cursor_18.24 Parabolic SAR
score 8
trend 上升
value 883.64
position SAR喺價下
distancePct 8.13
previousTrend 上升
ma50
value 888.4096
macd
macd 17.2313
trend 強烈看漲
signal 9.1027
histogram 8.1286
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 10
value 895.5812
position 連續5日>VWAP
consecutiveAbove 9
volume
rule Cursor_18.24 volume ratio
level 無力
ratio 0.92
score 4
avgVolume 812350
currentVolume 743592
derived
ma20 897.2955
ma50 888.4096
prevClose 955.76
avgVolume10 743979
avgVolume20 812350
changePercent 0.64
avgVolumeForScore 812350
ma_cross
ma20 897.2955
ma50 888.4096
rule Cursor_18.24 MA20/MA50 cross
cross 接近
score 6
prevMa20 894.1795
prevMa50 885.7148
spreadPct 1
isVolumeBreakout false
bollinger
lower 835.2755
upper 959.3155
position 上半部
rsi_short
value 83.59
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 0.92

Raw calculation JSON

 
{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.506009065579906,
        "turnoverUsdM": 715.24627296,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.MCK",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 913.6704,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 2,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 5,
      "take_profit_price": 1015.3123,
      "target_multiplier": 1.9,
      "technical_strength": 1.75,
      "take_profit_percent": 5.6
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.012018131159812,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 77.4,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 59.4,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 18
  },
  "market": {
    "ma20": 897.2955,
    "ma50": 888.4096,
    "close": 961.88,
    "prevClose": 955.76,
    "avgVolume20": 812350,
    "volumeRatio": 0.92,
    "changePercent": 0.64
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 18,
    "details": {
      "ret_5d": 0.0436273512998655,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 18,
      "vcp_bonus": 0,
      "vol_ratio": 0.8929676241713902,
      "ret_points": 8,
      "vol_points": 0,
      "range_ratio": 0.67127128758304,
      "volat_points": 0,
      "day_range_pct": 0.01590323117228763,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 8,
      "partial_history": false,
      "pullback_points": 0,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": true,
      "return_window_days": 5,
      "first_breakout_bonus": 2,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 77.4,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.4,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 68,
        "contribution": 3.4
      },
      {
        "raw": 13.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 66,
        "contribution": 13.2
      },
      {
        "raw": 10.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 68,
        "contribution": 10.2
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.8,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 68,
        "contribution": 6.8
      },
      {
        "raw": 20.8,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 69.33,
        "contribution": 20.8
      },
      {
        "raw": 3,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 30,
        "contribution": 3
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 59.4,
    "details": [
      "基本面分析總分: 3.4/5分",
      "資金流分析總分: 13.2/20分",
      "市場環境分析總分: 10.2/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.8/10分",
      "技術信號分析總分: 20.8/30分",
      "情緒分析: 3/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.4,
      "資金流": 13.2,
      "市場環境": 10.2,
      "情緒分析": 3,
      "技術信號": 20.8,
      "風險管理": 6.8
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0,
          "pePoints": 0.2,
          "epsPoints": 0.75,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 715.24627296,
          "volumePoints": 0.5,
          "revenuePoints": 0.6,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 2.4,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.MCK",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.21
            }
          },
          "trend": {
            "score": 4,
            "details": {
              "qqq": {
                "ma20": 741.33600115,
                "ma50": 726.5544004600001,
                "name": "QQQ",
                "close": 743.57001,
                "points": 2
              },
              "spy": {
                "ma20": 769.8689970499998,
                "ma50": 768.6025973799999,
                "name": "SPY",
                "close": 778.01001,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.506009065579906,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 3,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 0.3
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142821758,
                "url": "https://finnhub.io/api/news?id=281a1eb6ee8f02bdc10783752dc8224a241eda5565d2625fab63ff404e67c0f6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson has been a powerful long term winner. With the share price now at US$938.84, the real question is whether the business can keep generating cash flows that line up with that kind of run. With a Discounted Cash Flow (DCF) view available, the focus turns squarely to what the current price implies about the money the company can return to shareholders over time. Over the past 5 years the stock has delivered a very large 379.8% return, which puts a lot of past optimism about McKesson's...",
                "category": "company",
                "datetime": 1791818058,
                "headline": "McKesson (MCK) Stock Could Be 43% Undervalued Despite Its $1.4B Infusion Deal"
              },
              {
                "id": 142821757,
                "url": "https://finnhub.io/api/news?id=fbb0d7b782fa3b4aba78feb7fb325d6b48482c6a3eb9c1d87eb5906b0a671cef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) shares are in focus after the distributor reached an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032, reinforcing a long-running customer relationship. McKesson’s share price has been trending higher, with a 30-day share price return of 6.5% and a 90-day move of 16.9%. The 1-year total shareholder return of 22.5% and 5-year total shareholder return of about 3.8x suggest that recent contract wins and distribution...",
                "category": "company",
                "datetime": 1791814584,
                "headline": "McKesson (MCK) Extends CVS Deal, Is The Stock Fully Valued?"
              },
              {
                "id": 142820111,
                "url": "https://finnhub.io/api/news?id=4d051ea3729c9315fed5c13a05a00acf939426a9cf648456066898182aabec20",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "In October 2026, EPIC Pharmacies introduced a new wholesale distribution model naming McKesson as one of two primary partners, while McKesson separately announced an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032 across mail order, specialty, retail pharmacies, and distribution centers. Together, these moves highlight McKesson’s entrenched role in both large national chains and independent pharmacies, reinforcing its position...",
                "category": "company",
                "datetime": 1791810884,
                "headline": "Does New CVS and EPIC Deals Reshape McKesson’s Pharmacy Distribution Narrative (MCK)?"
              },
              {
                "id": 142765387,
                "url": "https://finnhub.io/api/news?id=fd6a7f2f5da2fe7193f181a051c1c9f775a76cc192965320d7c5f49ddd378d57",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson Corporation (NYSE:MCK) is expanding its specialty healthcare operations through a $5.8 billion acquisition (including debt) of Option Care Health, Inc. (NASDAQ:OPCH), partnering with private equity firm Clayton, Dubilier & Rice to take the infusion-services provider private. Announced on October 6, the transaction values Option Care at $32.05 per share, representing a 37% premium to […]",
                "category": "company",
                "datetime": 1791568158,
                "headline": "McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?"
              },
              {
                "id": 142727515,
                "url": "https://finnhub.io/api/news?id=a98edf85b5dcde01a756da2f0b29d3862357b7832cbb0676109ee8b36d807a77",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Suncoast Equity Management, an SEC-registered Investment Advisory (RIA), released its Q3 2026 investor letter for “U.S. Equity Large Cap Select Growth Strategy.” The letter can be downloaded here. The strategy advanced 4.2% after fees in Q3, compared to 2.3% for the S&P 500, marking a potential shift in market leadership. Despite lagging the S&P 500 […]",
                "category": "company",
                "datetime": 1791467120,
                "headline": "How AI Adoption Could Supercharge McKesson (MCK)"
              },
              {
                "id": 142727516,
                "url": "https://finnhub.io/api/news?id=55ccab73fbd163f318aa22cfe3b1c4547b68a2799ac938aefa2edbab8639c750",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Here is how McKesson (MCK) and Avantor, Inc. (AVTR) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1791463203,
                "headline": "Is McKesson (MCK) Outperforming Other Medical Stocks This Year?"
              },
              {
                "id": 142727517,
                "url": "https://finnhub.io/api/news?id=8949cd1235e6895465043289d3d02b3aaae3a0e95903c5cf7ef83568a1bfbbdb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
                "category": "company",
                "datetime": 1791462604,
                "headline": "Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?"
              },
              {
                "id": 142701312,
                "url": "https://finnhub.io/api/news?id=3adf33948f3c7026eb2167648dbe3e9e0085e8385ca908c9f4560f9439790774",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "In the closing of the recent trading day, McKesson (MCK) stood at $910.33, denoting a -1.23% move from the preceding trading day.",
                "category": "company",
                "datetime": 1791406803,
                "headline": "Here's Why McKesson (MCK) Fell More Than Broader Market"
              }
            ],
            "raw_source": [
              {
                "id": 142838335,
                "url": "https://finnhub.io/api/news?id=0a1891b04ecff22fcd901545af45eb3854af9eacd60ae8b33d71629bd6f72792",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.",
                "category": "company",
                "datetime": 1791875704,
                "headline": "3 Large-Cap Stocks to Keep an Eye On"
              },
              {
                "id": 142834486,
                "url": "https://finnhub.io/api/news?id=72ef390528f9357e6282d65e74062b0aaa8cbb4687effa371bd74cec6ec5d8c4",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2287251754/image_2287251754.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "McKesson stock is up 170% since 2022. Learn what’s driving growth, how recent M&A reshapes its portfolio, and if valuation limits upside.",
                "category": "company",
                "datetime": 1791856719,
                "headline": "McKesson: Re-Rated Again Amidst Increased M&A Efforts"
              },
              {
                "id": 142825453,
                "url": "https://finnhub.io/api/news?id=5c26291ca92708763cb3875dc9ab591493dcebb54023a277eefc0cab5d20c7fa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AbbVie trades at a 40% valuation discount but faces revenue concentration risk, while Eli Lilly's cardiometabolic dominance commands a premium.",
                "category": "company",
                "datetime": 1791849061,
                "headline": "AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142821758,
                "url": "https://finnhub.io/api/news?id=281a1eb6ee8f02bdc10783752dc8224a241eda5565d2625fab63ff404e67c0f6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson has been a powerful long term winner. With the share price now at US$938.84, the real question is whether the business can keep generating cash flows that line up with that kind of run. With a Discounted Cash Flow (DCF) view available, the focus turns squarely to what the current price implies about the money the company can return to shareholders over time. Over the past 5 years the stock has delivered a very large 379.8% return, which puts a lot of past optimism about McKesson's...",
                "category": "company",
                "datetime": 1791818058,
                "headline": "McKesson (MCK) Stock Could Be 43% Undervalued Despite Its $1.4B Infusion Deal"
              },
              {
                "id": 142821757,
                "url": "https://finnhub.io/api/news?id=fbb0d7b782fa3b4aba78feb7fb325d6b48482c6a3eb9c1d87eb5906b0a671cef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) shares are in focus after the distributor reached an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032, reinforcing a long-running customer relationship. McKesson’s share price has been trending higher, with a 30-day share price return of 6.5% and a 90-day move of 16.9%. The 1-year total shareholder return of 22.5% and 5-year total shareholder return of about 3.8x suggest that recent contract wins and distribution...",
                "category": "company",
                "datetime": 1791814584,
                "headline": "McKesson (MCK) Extends CVS Deal, Is The Stock Fully Valued?"
              },
              {
                "id": 142820111,
                "url": "https://finnhub.io/api/news?id=4d051ea3729c9315fed5c13a05a00acf939426a9cf648456066898182aabec20",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "In October 2026, EPIC Pharmacies introduced a new wholesale distribution model naming McKesson as one of two primary partners, while McKesson separately announced an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032 across mail order, specialty, retail pharmacies, and distribution centers. Together, these moves highlight McKesson’s entrenched role in both large national chains and independent pharmacies, reinforcing its position...",
                "category": "company",
                "datetime": 1791810884,
                "headline": "Does New CVS and EPIC Deals Reshape McKesson’s Pharmacy Distribution Narrative (MCK)?"
              },
              {
                "id": 142765387,
                "url": "https://finnhub.io/api/news?id=fd6a7f2f5da2fe7193f181a051c1c9f775a76cc192965320d7c5f49ddd378d57",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson Corporation (NYSE:MCK) is expanding its specialty healthcare operations through a $5.8 billion acquisition (including debt) of Option Care Health, Inc. (NASDAQ:OPCH), partnering with private equity firm Clayton, Dubilier & Rice to take the infusion-services provider private. Announced on October 6, the transaction values Option Care at $32.05 per share, representing a 37% premium to […]",
                "category": "company",
                "datetime": 1791568158,
                "headline": "McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?"
              },
              {
                "id": 142791266,
                "url": "https://finnhub.io/api/news?id=92546e8c535001a9c91c7067dcd42374edac84cda7c9007070044664e3809f11",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/09/benzinga-deal-dispatch2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "Major M&A deals this week include Viatris buys Pacira BioSciences, TowneBank acquires blueharbor, Energy Transfer buys Vacquero Midstream.",
                "category": "company",
                "datetime": 1791558208,
                "headline": "Deal Dispatch: Uber Buys ezCater For $2.3B, Skydance Takes Over Warner Bros., True Food Kitchen Bankruptcy"
              },
              {
                "id": 142764221,
                "url": "https://finnhub.io/api/news?id=9498b5cb98287f1f74d6cf582c78552f57037c256cff903ea892d9090ca6cee7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Option Care Health (NasdaqGS:OPCH) faces shareholder investigations into its proposed sale to Clayton, Dubilier & Rice and McKesson Corporation. Several securities law firms announced probes into whether OPCH's board secured a fair price and process for investors. The legal reviews of the Clayton, Dubilier & Rice and McKesson deal only capture one slice of the Option Care Health story. Our analysis turns up 3 other big wins for Option Care Health as well. For a broader view on income...",
                "category": "company",
                "datetime": 1791555360,
                "headline": "Option Care Health (OPCH) Faces Legal Review Of Its Proposed Takeover"
              },
              {
                "id": 142761782,
                "url": "https://finnhub.io/api/news?id=d2a3386c33af3eec6ee08a56e07e84c07a8081335d4b6fb1d7fd87dec46ff8b8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.",
                "category": "company",
                "datetime": 1791551710,
                "headline": "1 Profitable Stock to Target This Week and 2 We Ignore"
              },
              {
                "id": 142761781,
                "url": "https://finnhub.io/api/news?id=d38ba1ffb6808cdfa5bc887612cb2d66457921416a2b8302e9702c841cb61e6e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",
                "category": "company",
                "datetime": 1791545403,
                "headline": "If You Invested $1000 in McKesson a Decade Ago, This is How Much It'd Be Worth Now"
              },
              {
                "id": 142754684,
                "url": "https://finnhub.io/api/news?id=49dcab10b88a6e931005c6a6946230572ef84117f1fee25d712af82f91297e10",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Option Care Health shares have jumped into focus after a sharp move higher and a US$5.8b buyout agreement, which raises a straightforward question for investors who care about valuation. Does the current price around the deal level make sense when you line it up against the earnings the business is generating? The stock gained 37.5% over the past week, which puts fresh pressure on the question of whether that surge is matched by the company’s earnings power. The agreed US$32.05 per share...",
                "category": "company",
                "datetime": 1791537544,
                "headline": "Option Care Health (OPCH) Stock May Be Undervalued Despite The $5.8 Billion Buyout"
              },
              {
                "id": 142727515,
                "url": "https://finnhub.io/api/news?id=a98edf85b5dcde01a756da2f0b29d3862357b7832cbb0676109ee8b36d807a77",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Suncoast Equity Management, an SEC-registered Investment Advisory (RIA), released its Q3 2026 investor letter for “U.S. Equity Large Cap Select Growth Strategy.” The letter can be downloaded here. The strategy advanced 4.2% after fees in Q3, compared to 2.3% for the S&P 500, marking a potential shift in market leadership. Despite lagging the S&P 500 […]",
                "category": "company",
                "datetime": 1791467120,
                "headline": "How AI Adoption Could Supercharge McKesson (MCK)"
              },
              {
                "id": 142727516,
                "url": "https://finnhub.io/api/news?id=55ccab73fbd163f318aa22cfe3b1c4547b68a2799ac938aefa2edbab8639c750",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Here is how McKesson (MCK) and Avantor, Inc. (AVTR) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1791463203,
                "headline": "Is McKesson (MCK) Outperforming Other Medical Stocks This Year?"
              },
              {
                "id": 142727517,
                "url": "https://finnhub.io/api/news?id=8949cd1235e6895465043289d3d02b3aaae3a0e95903c5cf7ef83568a1bfbbdb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
                "category": "company",
                "datetime": 1791462604,
                "headline": "Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?"
              },
              {
                "id": 142723435,
                "url": "https://finnhub.io/api/news?id=08bacb4f6c36d927c4722aa7437f7f46dee36fd9755b9cab015cc8d26f7cf7dc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "CVS Health (NYSE:CVS) has extended its long-term pharmaceutical distribution agreements with Cardinal Health and McKesson through 2032. The renewed contracts keep CVS Health as a major customer for both wholesalers, supporting its nationwide pharmacy and retail operations. Management highlighted that the agreements cover prescription drug distribution across CVS Health's retail pharmacies and other dispensing channels. The extension of CVS Health's Cardinal Health and McKesson distribution...",
                "category": "company",
                "datetime": 1791454308,
                "headline": "What Does CVS Health (CVS) Gain From Extending Its Drug Distribution Deals To 2032?"
              },
              {
                "id": 142701312,
                "url": "https://finnhub.io/api/news?id=3adf33948f3c7026eb2167648dbe3e9e0085e8385ca908c9f4560f9439790774",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "In the closing of the recent trading day, McKesson (MCK) stood at $910.33, denoting a -1.23% move from the preceding trading day.",
                "category": "company",
                "datetime": 1791406803,
                "headline": "Here's Why McKesson (MCK) Fell More Than Broader Market"
              },
              {
                "id": 142698754,
                "url": "https://finnhub.io/api/news?id=97fe2a1aa70ca741e595b1dcd4f7fce3262709170ae4b991bb80da8000604569",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson is taking 49% of Option Care as more complex infusion treatments shift to homes and outpatient sites.",
                "category": "company",
                "datetime": 1791392820,
                "headline": "Option Care stock surges on McKesson's home-infusion bet"
              },
              {
                "id": 142699439,
                "url": "https://finnhub.io/api/news?id=33943256f1913b03b088d8cc24c4f218df31cfeb87c902b8455187d829366eca",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.",
                "category": "company",
                "datetime": 1791387903,
                "headline": "Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think \"Yes\""
              },
              {
                "id": 142697269,
                "url": "https://finnhub.io/api/news?id=3d8cfb67f6a2d53bce707598bb58139f6b502400fbd2d209972924d0d2e39af7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (NYSE:MCK) and Clayton Dubilier & Rice agreed to acquire Option Care Health in a US$5.8b transaction announced in 2026. The deal structure gives McKesson a significant minority stake in Option Care Health alongside private equity ownership. The acquisition expands McKesson's reach in specialty care, including home and outpatient medical infusion services outside traditional hospital settings. The Option Care Health acquisition and McKesson's new minority stake sit against a wider...",
                "category": "company",
                "datetime": 1791382254,
                "headline": "What Is McKesson (MCK) Gaining From This $5.8 Billion Option Care Deal?"
              },
              {
                "id": 140420211,
                "url": "https://finnhub.io/api/news?id=c9045c53ac19ad80d94a07c2e8320fa134ac76c18ad5824d79898864952688d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Intel downgraded, Marvell upgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1791381613,
                "headline": "Intel downgraded, Marvell upgraded: Wall Street's top analyst calls"
              },
              {
                "id": 142729390,
                "url": "https://finnhub.io/api/news?id=f9145b8bd4ccf7e7a3dbf4bf669e231db3f2901c8537fe2a2e8e5fc774a34eed",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "Leerink Partners  analyst Michael Cherny   maintains McKesson (NYSE:MCK) with a Outperform and raises the price target from $1030 to $1070.",
                "category": "company",
                "datetime": 1791377873,
                "headline": "Leerink Partners Maintains Outperform on McKesson, Raises Price Target to $1070"
              },
              {
                "id": 142695045,
                "url": "https://finnhub.io/api/news?id=2ee09dc71cf8c644183588dab4c9bdacc799dc8aceb783716bb6818266e8ffc8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
                "category": "company",
                "datetime": 1791374404,
                "headline": "Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?"
              },
              {
                "id": 142694026,
                "url": "https://finnhub.io/api/news?id=789a6ea7660236d7dcdecf3226305e350e88b1eb922d3bc106ebcc97cae78ac1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Option Care (OPCH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.",
                "category": "company",
                "datetime": 1791370680,
                "headline": "Strength Seen in Option Care (OPCH): Can Its 32.7% Jump Turn into More Strength?"
              },
              {
                "id": 142686463,
                "url": "https://finnhub.io/api/news?id=955f8a446297ab01638c6f13cc6db72490be0a5260f6afc2f1b0f72095be05cc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Companies In The Article Are:AMD,CEG,GOOG,OPCH,MCK and VST",
                "category": "company",
                "datetime": 1791359460,
                "headline": "Company News for Oct 7, 2026"
              },
              {
                "id": 142694607,
                "url": "https://finnhub.io/api/news?id=7a709be9f678e2f04f5132aa38eb3e0a155441b33f121af420628e5065bf515b",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/07/Stock-Market-Chart-With-Green-Candlestic.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "AMD, CEG, MRVL, OPCH, FCEL were among the stocks seen trending on Tuesday, Oct. 6, 2026.",
                "category": "company",
                "datetime": 1791321874,
                "headline": "AMD, Constellation Energy, Marvell Technology, Option Care Health and FuelCell Energy: Why These 5 Stocks Are on Investors' Radars Today"
              },
              {
                "id": 142667801,
                "url": "https://finnhub.io/api/news?id=9a8c24566e9da0f05dac10b4398012d1985a482bea3ab0f26d4c955aa9ee2c33",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Healthcare stocks were mixed late Tuesday afternoon, with the NYSE Healthcare Index up 0.2% and the",
                "category": "company",
                "datetime": 1791316298,
                "headline": "Sector Update: Healthcare Stocks Mixed Late Afternoon"
              },
              {
                "id": 142667802,
                "url": "https://finnhub.io/api/news?id=6b1de2f1930433751d01771318b68e4fcccf25d36d48eaaa5b9efd3d62504d66",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson Corporation (NYSE:MCK) was trading at around $916 on October 5, up 1.53% on the day and 21.72% over twelve months. The company collected $410.98 billion in revenue and kept $4.59 billion, a net margin of 1.12%. Its book value per share is negative $36.55. A business with almost no margin and no equity is […]",
                "category": "company",
                "datetime": 1791315976,
                "headline": "McKesson (MCK) Earns 1.12% on Sales and Has No Equity Left. How Does That Work?"
              },
              {
                "id": 142667803,
                "url": "https://finnhub.io/api/news?id=835a82886c5231beb0f2ef48f984cfb2d74676f90c16dd4a93a1cb34ade27720",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Option Care Health Inc. (NASDAQ:OPCH) soared by as much as 33 percent on Tuesday to $31.11 apiece following news that it is merging with Clayson, Dubilier, & Rice LLC (CD&R) and McKesson Corp. for $5.8 billion. In a joint statement, the firms said that they entered into a definitive agreement under which they will acquire […]",
                "category": "company",
                "datetime": 1791315928,
                "headline": "Option Care Health (OPCH) Rockets as CD&R, McKesson Table 37% Premium Bid"
              },
              {
                "id": 142667615,
                "url": "https://finnhub.io/api/news?id=1c5aa018d0e0c30ee0f8e265f88af23039a2252a01432476bbd1c276a7dfe4cc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "The provider of home and alternate site infusion services is being acquired.",
                "category": "company",
                "datetime": 1791313007,
                "headline": "Why Option Care Health Stock Skyrocketed on Tuesday"
              },
              {
                "id": 142666913,
                "url": "https://finnhub.io/api/news?id=25cca564f16bb177370a939e8f4b00c88ad3cb0d33d77bc83666d601d7cab63d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Healthcare stocks were mixed Tuesday afternoon, with the NYSE Healthcare Index up 0.1% and the State",
                "category": "company",
                "datetime": 1791308794,
                "headline": "Sector Update: Healthcare Stocks Mixed Tuesday Afternoon"
              },
              {
                "id": 142666914,
                "url": "https://finnhub.io/api/news?id=a9fd3b17d2f3ee6497fef7c9b418df133adea1c4eb5a7709915545a87ba8e70e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Drug distributor McKesson (MCK) and private investment firm Clayton Dubilier & Rice agreed to acquir",
                "category": "company",
                "datetime": 1791307805,
                "headline": "McKesson, CD&R to Buy Option Care Health in $5.8 Billion Deal"
              },
              {
                "id": 142666915,
                "url": "https://finnhub.io/api/news?id=92b0ec64118436fb85afc19f22f5f9013bcb2596b8d4c0d1cd3ec514dafddf0f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Option Health Care shares skyrocketed Tuesday after McKesson and CD&R agreed to buy the infusion services company for $5.8 billion.",
                "category": "company",
                "datetime": 1791302685,
                "headline": "Option Health Care Skyrockets On $5.8 Billion McKesson, CD&R Takeover"
              },
              {
                "id": 142695310,
                "url": "https://finnhub.io/api/news?id=414fc4d6fffa16bbaf44e711859053c69461f20865ed804f26d7cc01fedd9dde",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/06/Medical-Business-Handshake.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "Option Care Health agreed to a $5.8B buyout by CD&R and McKesson at $32.05 per share, pending shareholder and regulatory approvals.",
                "category": "company",
                "datetime": 1791300247,
                "headline": "Option Care Stock Trades Below McKesson's Deal Price — Here's the Spread"
              },
              {
                "id": 142665738,
                "url": "https://finnhub.io/api/news?id=c7f003a3d0774a1a1ccc0f0b92bddd2b1016b67d45817f6cfa69d5ac60037acc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Option Care Health has agreed to be acquired by CD&R and McKesson for $32. 05 per share in cash, representing approximately $5.",
                "category": "company",
                "datetime": 1791298111,
                "headline": "Option Care Health Agrees to $5.8 Billion Acquisition by CD&R and McKesson at $32.05 Per Share"
              },
              {
                "id": 142665445,
                "url": "https://finnhub.io/api/news?id=7d333eddfc3e8ce35da9d45ff3aa7acd138c244bd6355a80e4cba364c60f2695",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "On this episode of Stock Movers: - Option Care Health (OPCH) shares jumped after the Financial Times reports that McKesson and PE firm Clayton Dubilier & Rice are closing in on a deal to buy the provider of medical infusion services, that would value the business at more than $5b including debt. - Constellation Energy (CEG) shares are higher on news Google and Constellation Energy announced a long-term deal to bring 890 MW of new nuclear capacity on the PJM grid in Illinois, Pennsylvania and New Jersey. - SpaceX (SPCX) shares are the most actively traded in the premarket as NASA is close to announcing a bulk purchase of rocket launches to fuel its $30 billion drive to build a permanent base on the moon for humans to live and work. It also made Elon Musk a trillionaire once again.",
                "category": "company",
                "datetime": 1791297662,
                "headline": "Google, Constellation Energy Deal; SpaceX Rises on Talks with NASA | Stock Movers"
              },
              {
                "id": 142662955,
                "url": "https://finnhub.io/api/news?id=a79264aca14b600f8fd73874c113158161ffe44d0b27110d763f44af3d82f8bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Eli Lilly's revenue surged 44.7% in 2025, but Novo Nordisk trades at less than a quarter of its valuation multiple, a stark contrast that reshapes the risk-reward calculus.",
                "category": "company",
                "datetime": 1791293401,
                "headline": "Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142663226,
                "url": "https://finnhub.io/api/news?id=7e9ecf5c601a9fbf6b67264ae2ca8c8397a55179a12e2c766b21164e6032b182",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Key TakeawaysOption Care Health shares jumped 33% after CD&R and McKesson agreed to buy the company for $32. 05 per share in cash, about $5.",
                "category": "company",
                "datetime": 1791292972,
                "headline": "Option Care Health Soars 33% on $5.8 Billion Buyout by CD&R and McKesson: “A Great Outcome”"
              },
              {
                "id": 142665739,
                "url": "https://finnhub.io/api/news?id=9452824b7a657f2a87bd7be9d69481efcd1885609ba6f7d580da29bc398767ac",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Mckesson Corp (NYSE:MCK), the US healthcare services and drug distribution company, and Clayton Dubilier & Rice (CD&R), the private investment firm, have agreed to acquire Option Care Health (NASDAQ:OPCH) for approximately $5.8 billion. The buyers will pay $32.05 a share for Option...",
                "category": "company",
                "datetime": 1791290220,
                "headline": "McKesson and CD&R agree to acquire Option Care Health for $5.8 billion"
              },
              {
                "id": 142663228,
                "url": "https://finnhub.io/api/news?id=456fa693e4637a9a3173ec33fb17884700b5b455bda2294076068755caf4a96a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "NEW YORK & IRVING, Texas & BANNOCKBURN, Ill., October 06, 2026--CD&R, McKesson Corporation (NYSE: MCK) (\"McKesson\"), and Option Care Health, Inc. (Nasdaq: OPCH) (\"Option Care Health\") announced today that they have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health, an independent provider of home and alternate site infusion services, for $32.05 per share, reflecting a total enterprise value of approximately $5.8 billion. At the closing of the tran",
                "category": "company",
                "datetime": 1791288000,
                "headline": "CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health"
              },
              {
                "id": 142661963,
                "url": "https://finnhub.io/api/news?id=fa72d417c9aabb88ae86648a050b7cdf42c3205e2d766a2253ff7a7a88f4be7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "OPCH and CEG rallied on potential multibillion-dollar agreements, while CTVA gained after a JPMorgan upgrade and NKE fell on a sharp Berenberg downgrade.",
                "category": "company",
                "datetime": 1791285179,
                "headline": "Premarket Movers: OPCH, CEG Stocks Jump On Buyout Talks, Nuclear Deal – NKE Slides On ‘Sell’ Rating"
              },
              {
                "id": 142664435,
                "url": "https://finnhub.io/api/news?id=9a25394c93cdf8e0a5a1f8c7436bfe7478f0424b4181fc6ee3b15e541506707c",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/06/Mckesson-Office-Building-In-San-Francisc.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "CD&R and McKesson acquire Option Care Health in a $5.8 billion transaction at $32.05 per share as analysts assess acquisition terms.",
                "category": "company",
                "datetime": 1791283233,
                "headline": "McKesson Takes A Stake In Option Care — With An Option On The Rest"
              },
              {
                "id": 142658670,
                "url": "https://finnhub.io/api/news?id=a196c9329f5ee48f0734539e2e91f043eb2527b2508de76598e187b378d12cb1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "(Updates with the stock move in the headline and the second paragraph.) Option Care Health (OPCH)",
                "category": "company",
                "datetime": 1791281539,
                "headline": "Update: Market Chatter: Option Care Health's Shares Soar Pre-Bell as $5 Billion Acquisition Talks With Suitors Hit Advanced Stage"
              },
              {
                "id": 142664262,
                "url": "https://finnhub.io/api/news?id=99a73bb1a3a2114d2317328be02224642ad7d6142a5946c712725f2d1d39c779",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "CD&R, McKesson Corporation (NYSE: MCK) ("McKesson"), and Option Care Health, Inc. (NASDAQ:OPCH) ("Option Care Health") announced today that they have entered into a definitive agreement, under which",
                "category": "company",
                "datetime": 1791274376,
                "headline": "CD&R, McKesson Agree To Acquire Option Care Health For $32.05 Per share"
              },
              {
                "id": 142662208,
                "url": "https://finnhub.io/api/news?id=17dd429d423e0a7cc54685abed73252a2c704b9d2624f2650c57a37afcd780f1",
                "image": "https://static.seekingalpha.com/uploads/2026/10/4/saupload_needle_in_haystack.png",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "In our monthly Rare Stock Picks series, we're highlighting September 2026 investment picks. Click here for the list of September 2026 Buy recommendations.",
                "category": "company",
                "datetime": 1791273600,
                "headline": "Rare Stock Picks In September 2026 - From 21 Discerning Analysts"
              },
              {
                "id": 142666426,
                "url": "https://finnhub.io/api/news?id=9d934b87a25170b8cd17708c6faaf587e648ac7ff8c4001aeb7ba41155af950c",
                "image": "https://image.cnbcfm.com/api/v1/image/108084881-1736521567387-gettyimages-2192400361-BIZ-CONSTELLATION-CALPINE-BZ.jpeg?v=1744213721&w=1920&h=1080",
                "source": "CNBC",
                "related": "MCK",
                "summary": "These are the stocks posting the largest moves in early trading.",
                "category": "company",
                "datetime": 1791273050,
                "headline": "Stocks making the biggest moves premarket: Constellation Energy, Option Care Health, Lennar, P&G and more"
              },
              {
                "id": 142651138,
                "url": "https://finnhub.io/api/news?id=9114d67e717241f98a92cb00623d6fbd96d7c2d444e8304ade380578530a6046",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AMSTERDAM, October 06, 2026--Hadrian, the agentic AI offensive security platform, today announced a $40 million funding round co-led by Forgepoint Capital International and SmartFin, with participation from existing investors HV Capital, Motive Partners, Picus Capital and Oetker Ventures. The backing brings total funding to $65M and will fund expansion across EMEA and the U.S. and deepen investment in Hadrian's engineering and research teams.",
                "category": "company",
                "datetime": 1791270000,
                "headline": "Hadrian Raises $40M to Tackle the AI Hacking Cyber Security Crisis"
              },
              {
                "id": 142639807,
                "url": "https://finnhub.io/api/news?id=9ab2f9bc055160266f8118ea2253875ed0f7f2fd526d6abf6433ed4f78a80f8a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Option Care is in advanced talks after a joint bid from McKesson and private equity firm Clayton Dubilier & Rice, FT reported.",
                "category": "company",
                "datetime": 1791239257,
                "headline": "OPCH Stock Soars 22% After-Hours On $5B McKesson Buyout Talks"
              },
              {
                "id": 142639332,
                "url": "https://finnhub.io/api/news?id=f32078a3fdc62bf5dac28f5c3633d2960c9d16a4fa89c08061ee56c0b0350f7b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "A deal would value the infusion provider at more than $5 billion.",
                "category": "company",
                "datetime": 1791234960,
                "headline": "Report of Possible $5 Billion Takeover Bid Sends Option Care Health Stock Higher"
              },
              {
                "id": 142639221,
                "url": "https://finnhub.io/api/news?id=5d550c1eea6627c4239e7e0734fe6356ecd9cb364463c68f6b2ce3d6fc895d48",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Investing.com -- Shares of Option Care Health (NASDAQ: OPCH) surged 22% in after-hours trading on Monday following a Financial Times report that healthcare giant McKesson and private equity firm Clayton Dubilier & Rice (CD&R) are in advanced talks to acquire the infusion services provider. The potential transaction is expected to value the company at more than $5 billion, including debt.",
                "category": "company",
                "datetime": 1791233087,
                "headline": "Option Care Health surges 22% on report of $5 billion takeover by McKesson, CD&R"
              },
              {
                "id": 142664263,
                "url": "https://finnhub.io/api/news?id=1b0207b584fa51908704d2ed58a42c554e94e0cb7f6fb57e9d65c4e3b3b4184b",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "McKesson (NYSE:MCK) has outperformed the market over the past 20 years by 6.56% on an annualized basis producing an average annual return of 15.64%. Currently, McKesson has a market capitalization of $106.73 billion.",
                "category": "company",
                "datetime": 1791229517,
                "headline": "Here's How Much $1000 Invested In McKesson 20 Years Ago Would Be Worth Today"
              },
              {
                "id": 142636689,
                "url": "https://finnhub.io/api/news?id=fb56f6ad3dd10485a7f4e1b6c50af21909d14625d8bbab09f52060bc2db42aac",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "One Number: $7.2 Million in Revenue Per Employee NVIDIA (NASDAQ:NVDA) now brings in about $7.2 million in revenue for each person on its payroll. That figure comes from $302.97 billion in trailing 12-month revenue across roughly 42,000 employees, and it is 5.8x higher than it was three years ago. The revenue figure gets the attention, […]",
                "category": "company",
                "datetime": 1791215517,
                "headline": "Nvidia Generates $7.2 Million per Employee, Up 500% in 3 Years. This Number Is Even More Astounding."
              },
              {
                "id": 142634318,
                "url": "https://finnhub.io/api/news?id=0f791ab75f6474bac4337db895517f5d04520e577a02ed846ff21b5c8bd44ebe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "IRVING, Texas, October 05, 2026--InspiroGene™ by McKesson today announced the publication of its third annual 2026 Cell and Gene Therapy Report.",
                "category": "company",
                "datetime": 1791198000,
                "headline": "New 2026 Cell and Gene Therapy Report Charts the Path from Scientific Progress to Patient Access"
              },
              {
                "id": 142624185,
                "url": "https://finnhub.io/api/news?id=773d3787e684fba498bba3b49094c209329c0e46fcca5973e7c495eb6d0c1b89",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "One offers a more affordable entry point while the other boasts some of the highest profit margins in the sector. The choice comes down to whether you prioritize income stability or growth potential.",
                "category": "company",
                "datetime": 1791124497,
                "headline": "Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142601554,
                "url": "https://finnhub.io/api/news?id=8f6872a09480f4ec64796fb827f731e470b37cb5e16d2cfb3fdb8bc48637fc73",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Bond yields have surged to levels not seen in decades, mortgage rates now sit above 7% and big institutional players are pulling back from Treasuries. That combination is reshaping how investors think about risk, cash flow and balance sheet strength. This piece walks through three large cap stocks exposed to these rate moves, all filtered for solid free cash flow, to help you judge which stories might deserve a closer look now. The three examples below are only a sample set, and the full...",
                "category": "company",
                "datetime": 1791004184,
                "headline": "3 Cash Rich US Stocks Investors Are Watching As Bond Yields Stay High"
              },
              {
                "id": 142588574,
                "url": "https://finnhub.io/api/news?id=84ccaec2825b0d28abb6caaf6d3fe52e576a7aa1808c568dab8b141291eaad47",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Medical-dental supplies see durable demand from specialty care, AI and aging trends, with McKesson and peers navigating tariffs and inflation.",
                "category": "company",
                "datetime": 1790944860,
                "headline": "Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex"
              },
              {
                "id": 142579898,
                "url": "https://finnhub.io/api/news?id=dfb24a232bcd5528c08c4b29ac1b774ea3ccb4016e22070e2d17a4961607b3f2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Companies In The News Are: ACN, AYI, MCK, PRGS.",
                "category": "company",
                "datetime": 1790925600,
                "headline": "Company News for Oct 2, 2026"
              },
              {
                "id": 142564194,
                "url": "https://finnhub.io/api/news?id=99afa9069d93664d93769b266460cdde5fca26574903426f9129704188e98e59",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "The company extended its existing partnership with a major pharmacy chain.",
                "category": "company",
                "datetime": 1790899181,
                "headline": "Why McKesson Stock Soared More Than 5% Higher Today"
              },
              {
                "id": 142563714,
                "url": "https://finnhub.io/api/news?id=e98e6cb8cdda4ddef333d043a63b0f58a5549656408252b35331ef9926a27d67",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AbbVie boasts stronger revenue growth and free cash flow, while Bristol Myers Squibb trades at half the valuation with nearly double the profit margin.",
                "category": "company",
                "datetime": 1790894462,
                "headline": "AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142563821,
                "url": "https://finnhub.io/api/news?id=78fc971fe61f574792be360b18b4773919e6ef619c3f66fee267816df3d9ab21",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Shares of healthcare distributor and services company McKesson (NYSE:MCK) jumped 4.4% in the afternoon session after the company reached an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032.",
                "category": "company",
                "datetime": 1790892787,
                "headline": "Why McKesson (MCK) Stock Is Trading Up Today"
              },
              {
                "id": 142560293,
                "url": "https://finnhub.io/api/news?id=b20e08d06594043d73774dff90800dc69a3fc3d1ae58095ba1758b392220c4e2",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "MCK",
                "summary": "Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.",
                "category": "company",
                "datetime": 1790872502,
                "headline": "Which S&P500 stocks are moving on Thursday?"
              },
              {
                "id": 142560961,
                "url": "https://finnhub.io/api/news?id=8c29bad414b888ad54769f6de437407f88dbac1694c85437f21feccb43df9fce",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Bond yields hit their highest level in two decades, pressuring blue chip dividend stocks and weighing on the broader market, today, Oct. 1, 2026.",
                "category": "company",
                "datetime": 1790871633,
                "headline": "Stock Market Midday, Oct. 1: Stocks Edge Lower as Treasury Yields Surge to 24-Year High"
              },
              {
                "id": 142559894,
                "url": "https://finnhub.io/api/news?id=2d422b2dc387e4525b846d85e51029105cafeb0b86467b57b8d2a7a1ad538a50",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Investing.com -- McKesson Corporation (NYSE:MCK) shares rose 4.4% Thursday following the announcement of an extended pharmaceutical distribution agreement with CVS Health through June 2032.",
                "category": "company",
                "datetime": 1790867094,
                "headline": "McKesson extends CVS deal; shares rise"
              },
              {
                "id": 142559043,
                "url": "https://finnhub.io/api/news?id=59a342f752939553f2e3d8e29e06764b348e36d80fb4ad00f938a1f983b96856",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "MCK",
                "summary": "Looking for the S&P500 stocks that are experiencing notable gaps on Thursday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1790865302,
                "headline": "These S&P500 stocks are gapping in today's session"
              },
              {
                "id": 142557887,
                "url": "https://finnhub.io/api/news?id=4da254ec7e298a4369c4d7487af3ab3e23bac54bf00a3b6c00fcefe111f00e57",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "RICHMOND, Va., October 01, 2026--EPIC Pharmacies, Inc. (EPIC Rx), a nationwide buying group dedicated to supporting and empowering independent pharmacies, today announced an expanded approach to wholesale distribution that provides member pharmacies with greater choice and flexibility in how they purchase medications. As a champion of pharmacy independence, EPIC Rx is putting greater control in the hands of pharmacy owners and operators, allowing them to select the wholesale partner that best al",
                "category": "company",
                "datetime": 1790859600,
                "headline": "EPIC Rx Introduces New Wholesale Distribution Options for Member Pharmacies"
              },
              {
                "id": 142557888,
                "url": "https://finnhub.io/api/news?id=e5de8a290d534514dd1059d53da492c4f3d6c0ccb367623167bd969120f8e626",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "IRVING, Texas, October 01, 2026--McKesson Corporation (NYSE: MCK) announced today that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies, retail pharmacies, and distribution centers through June 2032.",
                "category": "company",
                "datetime": 1790856180,
                "headline": "McKesson Corporation Extends Pharmaceutical Distribution Agreement with CVS Health"
              },
              {
                "id": 142588192,
                "url": "https://finnhub.io/api/news?id=a5de3a7978cd533cf49a7a5e0e5decbfe12ed24021ec5e06c8d8665b7e74714a",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/01/Chandler--Arizona---April-08-2023cvs-Hea.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "Cardinal Health and McKesson extend drug distribution deals with CVS Health through June 2032, reaffirming FY2027 adjusted earnings guidance.",
                "category": "company",
                "datetime": 1790855987,
                "headline": "Cardinal Health, McKesson Double Down on CVS Deals Through 2032"
              },
              {
                "id": 142557889,
                "url": "https://finnhub.io/api/news?id=6aef2f6be077d7cadc16d7f461abb00cb9e3ac60b722a6e258a13f9e2397edee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.",
                "category": "company",
                "datetime": 1790855760,
                "headline": "5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve"
              },
              {
                "id": 142559134,
                "url": "https://finnhub.io/api/news?id=03841322c4307650d2508ff35854a44d31563f24911a6c231a3e7804ecb9c8c7",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "McKesson Corporation (NYSE: MCK) announced today it is reaffirming its fiscal year 2027 adjusted EPS guidance of $44.20 to $45.00 and its long-term adjusted EPS growth rate of 13% to 16%. Further updates will be",
                "category": "company",
                "datetime": 1790841949,
                "headline": "McKesson Reiterates FY27 Adjusted EPS Outlook Range Of $44.20 To $45"
              },
              {
                "id": 142524984,
                "url": "https://finnhub.io/api/news?id=3087ab39040439f1d4ce75aaf55c3147841fe9b80c9fa54e439fb603179ce87e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) reached $853.81 at the closing of the latest trading day, reflecting a -1.27% change compared to its last close.",
                "category": "company",
                "datetime": 1790802004,
                "headline": "McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to Know"
              },
              {
                "id": 142522612,
                "url": "https://finnhub.io/api/news?id=39c8b0d65d016661fc240daa4dc5d5c622c60cf374cedbb1865d36d02d4b09f9",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2233434722/image_2233434722.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "Cardinal Health remains a Buy, driven by robust FY2026 results, strong cash flow, and credible FY2027 guidance. Read more on CAH stock here.",
                "category": "company",
                "datetime": 1790780492,
                "headline": "Cardinal Health: I'm Still Buying After Checking The Numbers"
              },
              {
                "id": 142500485,
                "url": "https://finnhub.io/api/news?id=2e4cca44897a22fa2022d1bef94f65c51be5e651759eb8ed851cbfaf5475f9c5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson's specialty distribution, oncology and GLP-1 growth are driving earnings, while drug pricing, margin pressure and policy uncertainty pose challenges.",
                "category": "company",
                "datetime": 1790704620,
                "headline": "Here's Why You Should Retain McKesson Stock in Your Portfolio for Now"
              },
              {
                "id": 142426691,
                "url": "https://finnhub.io/api/news?id=68c6d99ecb3945426214e324f0415ce3bfad6b187bddbedeb0207483edb9d72e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AbbVie bets on pipeline diversification amid patent cliffs, while J&J's higher profitability masks litigation risks, a choice between growth ambition and defensive stability.",
                "category": "company",
                "datetime": 1790378161,
                "headline": "AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142432371,
                "url": "https://finnhub.io/api/news?id=403589f5a28b768b40e6b9e54ab5a5d2aa8836e772aecee6e6c1fa8830560d81",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "Get the weekly summary of dividend changes for Dividend Champions, Contenders & Challengers, plus upcoming ex-dividend and pay dates.",
                "category": "company",
                "datetime": 1790377479,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week September 27"
              },
              {
                "id": 142426107,
                "url": "https://finnhub.io/api/news?id=3c443fa180b195a06f52ced8a8b5d4a24a692b809dd175762819f3d8ae4b1d19",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AbbVie pivots toward newer immunology drugs while Pfizer leans on acquisitions to offset pandemic decline, but their financial profiles and valuations tell starkly different stories.",
                "category": "company",
                "datetime": 1790371321,
                "headline": "AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026?"
              },
              {
                "id": 142425604,
                "url": "https://finnhub.io/api/news?id=878962ab226368893bd0e3a112a0136b824ea77667f2813f3b7b015570b4a55b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) is back in focus after its share price dipped 1.2%, trailing the broader market, as investors weigh mixed earnings estimates against the company’s raised full-year adjusted EPS guidance and specialty-led healthcare footprint. Recent trading has been choppy for McKesson, with the share price slipping 3.95% over the past 30 days even after a 13.86% 90 day share price return and a 5.58% share price gain year to date. That near term hesitation sits against a much stronger backdrop,...",
                "category": "company",
                "datetime": 1790359848,
                "headline": "McKesson (MCK) Lifted Its Guidance, Is The Stock Still 11% Undervalued?"
              },
              {
                "id": 142386749,
                "url": "https://finnhub.io/api/news?id=a527e44c28e4d2901c54177a49412223ada2e94c09864f8c6483e6026a3335f0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Novo Nordisk trades at a steep discount on earnings and sales, while AbbVie grapples with patent cliffs and pricing pressure, but profitability tells a different story.",
                "category": "company",
                "datetime": 1790284741,
                "headline": "AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142386737,
                "url": "https://finnhub.io/api/news?id=8eb972c08a04133027eb920e3fc3b121b93a21bf2259240dd130d95008f10fd5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AbbVie leans on legacy income and portfolio transition, while Eli Lilly rides explosive growth in weight-loss drugs, but at vastly different valuations.",
                "category": "company",
                "datetime": 1790281321,
                "headline": "AbbVie vs. Eli Lilly: Which Star Pharma Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142384809,
                "url": "https://finnhub.io/api/news?id=0d14123a814a7697551c1b9721cb42f411a5c2f323385dcb61a4efd61c8eba17",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "CAH's specialty-led growth, stronger EPS outlook and improving estimate momentum set up a compelling case against MCK.",
                "category": "company",
                "datetime": 1790264700,
                "headline": "Cardinal Health vs. McKesson: Which Healthcare Stock Is Better?"
              },
              {
                "id": 142422371,
                "url": "https://finnhub.io/api/news?id=2f207591964d54e3b97e4b59682480e0b1a5ab5aa1bb6648b9d6841d6b017654",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_4.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 22.21% on an annualized basis producing an average annual return of 34.23%. Currently, McKesson has a market capitalization of $102.91 billion.",
                "category": "company",
                "datetime": 1790253034,
                "headline": "Here’s How Much You Would Have Made Owning McKesson Stock In The Last 5 Years"
              },
              {
                "id": 142366009,
                "url": "https://finnhub.io/api/news?id=6c645c81b5d6816582aa97b3f057edf088458209713d2f7c8547976c7d4cc6a1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "The latest trading day saw McKesson (MCK) settling at $880.5, representing a -1.2% change from its previous close.",
                "category": "company",
                "datetime": 1790200803,
                "headline": "Why McKesson (MCK) Dipped More Than Broader Market Today"
              },
              {
                "id": 142359800,
                "url": "https://finnhub.io/api/news?id=21e8d0e8b0fadadc3e3fa8b51bd2ad4e5bbe2da4679cc19d5fb4855b1a5b0ec9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
                "category": "company",
                "datetime": 1790168407,
                "headline": "McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know"
              },
              {
                "id": 142359801,
                "url": "https://finnhub.io/api/news?id=e2eeb3460907b49da59df8b243b36bf8808d025644ac999e210fc49d00082d55",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "IRVING, Texas, September 23, 2026--McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2027 financial results after market close on Wednesday, November 4, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.",
                "category": "company",
                "datetime": 1790164800,
                "headline": "McKesson Corporation Announces Second Quarter Fiscal 2027 Earnings Release Date"
              },
              {
                "id": 142337859,
                "url": "https://finnhub.io/api/news?id=5e90da72b9445f8f269fe769a77eee231cb102829bca91c22fcabee80a02ffe0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "CAH is expanding its MSO strategy across specialty care, with Solaris and broader services aimed at scaling physician networks.",
                "category": "company",
                "datetime": 1790083920,
                "headline": "Can CAH's MSO Expansion Unlock Growth in Specialty Care Delivery?"
              },
              {
                "id": 142315583,
                "url": "https://finnhub.io/api/news?id=eabc3a29647ff9263112fd7e84226baafd3f2b824601a72d0d96d7ab23b38c35",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Since March 2026, McKesson has been in a holding pattern, floating around $872.99. The stock also fell short of the S&P 500’s 16.4% gain during that period.",
                "category": "company",
                "datetime": 1790021665,
                "headline": "3 Reasons MCK Has Explosive Upside Potential"
              },
              {
                "id": 142258086,
                "url": "https://finnhub.io/api/news?id=609ac00b5cd43a3cdf9674d3ec513292d7a9ffa17a752ca1e6ecd17075ce8b5f",
                "image": "https://image.cnbcfm.com/api/v1/image/108364583-17896719001789671898-48440813815-1080pnbcnews.jpg?v=1789671899&w=1920&h=1080",
                "source": "CNBC",
                "related": "MCK",
                "summary": "Skyler Weinand, Regan Capital CIO, joins 'Power Lunch' to discuss the best stocks for a sustained rate hike cycle.",
                "category": "company",
                "datetime": 1789657793,
                "headline": "Really like Northrop Grumman as a value play, says Regan Capital's Skyler Weinand"
              },
              {
                "id": 142220724,
                "url": "https://finnhub.io/api/news?id=825ed465d57b9b84b5b396a439153daf594d2d7e37c3d9353a2aed5c3fb912fd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.",
                "category": "company",
                "datetime": 1789639817,
                "headline": "1 Unpopular Stock That Deserves Some Love and 2 We Turn Down"
              },
              {
                "id": 142197211,
                "url": "https://finnhub.io/api/news?id=fa5c0c94bd0a3b0d0eb0b39a7c41bebafa4e33cde64a461c0074cfb715c4f818",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” second-quarter 2026 investor letter. The letter can be downloaded here. The second quarter reflected a sharp shift from geopolitical uncertainty and oil market volatility to a powerful equity rally led by semiconductor companies. Despite the broader market strength, the Fund declined […]",
                "category": "company",
                "datetime": 1789571094,
                "headline": "Alluvium Raised Its McKesson (MCK) Stake as Long-Term Growth Expectations Remain Strong"
              },
              {
                "id": 142158577,
                "url": "https://finnhub.io/api/news?id=df523848265bf481e0a7f7ef18142b6d13d71c1fffdfc497171396fd88af6155",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson recently raised its full-year EPS guidance, projecting approximately 13%–15% growth (15%–17% excluding certain prior-year items), and outlined plans to rebrand its Medical-Surgical unit as Wellverse with a potential IPO targeted for the second half of 2027, alongside a pending acquisition of Precision Medicine Group to expand oncology and biopharma-services capabilities, subject to regulatory approval. This combination of upgraded earnings expectations, portfolio reshaping around...",
                "category": "company",
                "datetime": 1789463504,
                "headline": "Did McKesson’s (MCK) EPS Hike and Oncology Push Just Redefine Its Investment Narrative?"
              },
              {
                "id": 142139308,
                "url": "https://finnhub.io/api/news?id=8f218e6f7b910d123201ac23fb800ce70f363d4a3dd35a78f17158dcc3292a09",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AbbVie is profitable, growing, and paying a rising dividend. CRISPR is burning cash in pursuit of a gene-editing breakthrough that could reshape medicine.",
                "category": "company",
                "datetime": 1789398055,
                "headline": "AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142137295,
                "url": "https://finnhub.io/api/news?id=dcc4b288ae6e93f54675969bd802a9ab516ad006a056529faa42c98979a51c3e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (NYSE:MCK) executives said the company’s first-quarter performance supported a higher full-year earnings outlook, citing broad-based growth across its North American Pharmaceutical, Oncology & Multispecialty and Prescription Technology Solutions businesses. Speaking at the Morgan Stanl",
                "category": "company",
                "datetime": 1789390938,
                "headline": "McKesson Raises Outlook, Eyes Oncology Growth With Precision Medicine Deal"
              },
              {
                "id": 142135993,
                "url": "https://finnhub.io/api/news?id=da1e88d3e7f35b8059dfd20fd97ed62f63419a669479637d7a9f61c48ee2f6bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Amgen trades at a cheaper valuation but carries higher leverage, while Vertex boasts pristine finances and 32% net margins, a classic trade-off between value and quality.",
                "category": "company",
                "datetime": 1789383825,
                "headline": "Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142138058,
                "url": "https://finnhub.io/api/news?id=4d90149136c5f41327c113354fdc5242c1583fff9332db691b343e5ab0a73218",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "McKesson Corporation (MCK) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 7:45 AM EDTCompany ParticipantsBrian Tyler - CEO &...",
                "category": "company",
                "datetime": 1789381900,
                "headline": "McKesson Corporation (MCK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript"
              },
              {
                "id": 142163085,
                "url": "https://finnhub.io/api/news?id=ed034ae5db6b4ec4061bdcecf7d571dc60aa47a4e0212d5e8b8b81b1993087e9",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "RBC Capital  analyst Ryan Halsted   reiterates McKesson (NYSE:MCK) with a Sector Perform and maintains $845 price target.",
                "category": "company",
                "datetime": 1789379722,
                "headline": "RBC Capital Reiterates Sector Perform on McKesson, Maintains $845 Price Target"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.3,
            "source_article_count": 94,
            "discarded_article_count": 73
          },
          "sentimentPoints": 3
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 20.8,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.9,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50；收盤突破20日高位；Ready=N；Confirm=Y",
            "vcp_metrics": {
              "up_days": 7,
              "vol_ref": 848630,
              "down_days": 2,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 717310,
              "avg_vol_20": 832720,
              "avg_vol_30": 848630,
              "range_pct_10": 0.11326777768536618,
              "range_pct_20": 0.11326777768536618,
              "range_pct_30": 0.11326777768536618,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 1,
              "breakout_20d_ok": true,
              "vol_ratio_10_30": 0.8452564721963636,
              "dist_to_20d_high": -0.005898111414478662,
              "down_shrink_days": 2,
              "breakout_level_20d": 956.23999,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 1
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.506009065579906,
              "turnoverUsdM": 715.24627296,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.MCK",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 913.6704,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 2,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 5,
            "take_profit_price": 1015.3123,
            "target_multiplier": 1.9,
            "technical_strength": 1.75,
            "take_profit_percent": 5.6
          },
          "positionPoints": 1.6,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.012018131159812,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 24.1048,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.51
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 174.75
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0221
    },
    "kdj": {
      "d": 81.28,
      "j": 106.62,
      "k": 89.73,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 55.72
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": -3416908,
      "recentSlope": 515979.2,
      "previousSlope": -389040
    },
    "rsi": 73.32,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 883.64,
      "position": "SAR喺價下",
      "distancePct": 8.13,
      "previousTrend": "上升"
    },
    "ma50": 888.4096,
    "macd": {
      "macd": 17.231326948893184,
      "trend": "強烈看漲",
      "signal": 9.102747044402234,
      "histogram": 8.12857990449095
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 895.5812,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 9
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.92,
      "score": 4,
      "avgVolume": 812350,
      "currentVolume": 743592
    },
    "derived": {
      "ma20": 897.2955,
      "ma50": 888.4096,
      "prevClose": 955.76,
      "avgVolume10": 743979,
      "avgVolume20": 812350,
      "changePercent": 0.64,
      "avgVolumeForScore": 812350
    },
    "ma_cross": {
      "ma20": 897.2955,
      "ma50": 888.4096,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 894.1795,
      "prevMa50": 885.7148,
      "spreadPct": 1,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 835.2755,
      "upper": 959.3155,
      "position": "上半部"
    },
    "rsi_short": 83.59,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.92
    }
  }
}

Raw metrics JSON

 
{
  "close": 961.88,
  "volume": 743592,
  "changePercent": 0.64
}

Scores are derived from cached daily market data using the Solorank 110-point standard. Solorank provides research support only and does not provide financial advice or buy/sell recommendations.